-
1
-
-
0027139351
-
Development, characterization, efficacy and mode of action of AmBisome, a unilamellar liposomal formulation of amphotericin B
-
Adler-Moore, J.P., Proffitt, R.T., 1993. Development, characterization, efficacy and mode of action of ambisome, a unilamellar liposomal formulation of amphotericin B. J. Liposome Res. 3, 429-450. (Pubitemid 24007409)
-
(1993)
Journal of Liposome Research
, vol.3
, Issue.3
, pp. 429-450
-
-
Adler-Moore, J.P.1
Proffitt, R.T.2
-
2
-
-
0032763329
-
Efficacy of the triazole SCH 56592 against Leishmania amazonensis and Leishmania donovani in experimental murine cutaneous and visceral leishmaniases
-
Al-Abdely, H.M., Graybill, J.R., Loebenberg, D., Melby, P.C., 1999. Efficacy of the triazole SCH 56592 against Leishmania amazonensis and Leishmania donovani in experimental murine cutaneous and visceral leishmaniases. Antimicrob. Agents Chemother. 43, 2910-2914.
-
(1999)
Antimicrob. Agents Chemother.
, vol.43
, pp. 2910-2914
-
-
Al-Abdely, H.M.1
Graybill, J.R.2
Loebenberg, D.3
Melby, P.C.4
-
3
-
-
77954012351
-
Chitosancoated antifungal formulations for nebulisation
-
Albasarah, Y.Y., Somavarapu, S., Stapleton, P., Taylor, K.M., 2010. Chitosancoated antifungal formulations for nebulisation. J. Pharm. Pharmacol. 62, 821-828.
-
(2010)
J. Pharm. Pharmacol.
, vol.62
, pp. 821-828
-
-
Albasarah, Y.Y.1
Somavarapu, S.2
Stapleton, P.3
Taylor, K.M.4
-
4
-
-
34547899919
-
Solid lipid nanoparticles as a drug delivery system for peptides and proteins
-
DOI 10.1016/j.addr.2007.04.007, PII S0169409X07000439, Lipid Nanoparticles: Recent Advances
-
Almeida, A.J., Souto, E., 2007. Solid lipid nanoparticles as a drug delivery system for peptides and proteins. Adv. Drug Deliv. Rev. 59, 478-490. (Pubitemid 47260710)
-
(2007)
Advanced Drug Delivery Reviews
, vol.59
, Issue.6
, pp. 478-490
-
-
Almeida, A.J.1
Souto, E.2
-
5
-
-
42349108596
-
The relationship between leishmaniasis and AIDS: The second 10 years
-
DOI 10.1128/CMR.00061-07
-
Alvar, J., Aparicio, P., Aseffa, A., Den Boer, M., Canavate, C., Dedet, J.P., Gradoni, L., Ter Horst, R., Lopez-Velez, R., Moreno, J., 2008. The relationship between leishmaniasis and AIDS: the second 10 years. Clin. Microbiol. Rev. 21, 334-359, table of contents. (Pubitemid 351555511)
-
(2008)
Clinical Microbiology Reviews
, vol.21
, Issue.2
, pp. 334-359
-
-
Alvar, J.1
Aparicio, P.2
Aseffa, A.3
Den, B.M.4
Canavate, C.5
Dedet, J.-P.6
Gradoni, L.7
Ter, H.R.8
Lopez-Velez, R.9
Moreno, J.10
-
6
-
-
33646823616
-
Chemotherapy in the Treatment and Control of Leishmaniasis
-
Academic Press, London
-
Alvar, J., Croft, S., Olliaro, P., David, H.M., 2006. Chemotherapy in the Treatment and Control of Leishmaniasis, Advances in Parasitology. Academic Press, London, pp. 223-274.
-
(2006)
Advances in Parasitology
, pp. 223-274
-
-
Alvar, J.1
Croft, S.2
Olliaro, P.3
David, H.M.4
-
7
-
-
0021089252
-
Delivery of liposome-encapsulated drugs to macrophages
-
Alving, C.R., 1983. Delivery of liposome-encapsulated drugs to macrophages. Pharmacol. Ther. 22, 407-424. (Pubitemid 14201457)
-
(1983)
Pharmacology and Therapeutics
, vol.22
, Issue.3
, pp. 407-424
-
-
Alving, C.R.1
-
8
-
-
45849094442
-
Lipid nano spheres (LNSs) for enhanced oral bioavailability of amphotericin B: Development and characterization
-
DOI 10.1166/jbn.2007.029
-
Amarji, B., Ajazuddin Raghuwanshi, D., Vyas, S.P., Kanaujia, P., 2007. Lipid nano spheres (LNSs) for enhanced oral bioavailability of amphotericin B: development and characterization. J. Biomed. Nanotechnol. 3, 264-269. (Pubitemid 351877152)
-
(2007)
Journal of Biomedical Nanotechnology
, vol.3
, Issue.3
, pp. 264-269
-
-
Amarji, B.1
Ajazuddin2
Raghuwanshi, D.3
Vyas, S.P.4
Kanaujia, P.5
-
9
-
-
0028948839
-
A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability
-
Amidon, G., Lennernäs, H., Shah, V., Crison, J., 1995. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 12, 413-420.
-
(1995)
Pharm. Res.
, vol.12
, pp. 413-420
-
-
Amidon, G.1
Lennernäs, H.2
Shah, V.3
Crison, J.4
-
10
-
-
0035121778
-
Nouvelles formes lipidiques de l'amphotéricine B. Revue de la littérature
-
Andrès, E., Tiphine, M., Letscher-Bru, V., Herbrecht, R., 2001. Nouvelles formes lipidiques de l'Amphotericine B. Revue de la littérature. La Revue de Médecine Interne 22, 141-150. (Pubitemid 32154333)
-
(2001)
Revue de Medecine Interne
, vol.22
, Issue.2
, pp. 141-150
-
-
Andres, E.1
Tiphine, M.2
Letscher-Bru, V.3
Herbrecht, R.4
-
11
-
-
70349921511
-
Aqueous-core lipid nanocapsules for encapsulating fragile hydrophilic and/or lipophilic molecules
-
Anton, N., Saulnier, P., Gaillard, C., Porcher, E., Vrignaud, S., Benoit, J.P., 2009. Aqueous-core lipid nanocapsules for encapsulating fragile hydrophilic and/or lipophilic molecules. Langmuir 25, 11413-11419.
-
(2009)
Langmuir
, vol.25
, pp. 11413-11419
-
-
Anton, N.1
Saulnier, P.2
Gaillard, C.3
Porcher, E.4
Vrignaud, S.5
Benoit, J.P.6
-
12
-
-
28844499143
-
Lipid formulations of amphotericin B: Where are we today?
-
DOI 10.1016/j.mycmed.2005.06.005, PII S1156523305000776
-
Antoniadou, A., Dupont, B., 2005. Lipid formulations of amphotericin B: where are we today? J. Med. Mycol. 15, 230-238. (Pubitemid 41774269)
-
(2005)
Journal de Mycologie Medicale
, vol.15
, Issue.4
, pp. 230-238
-
-
Antoniadou, A.1
Dupont, B.2
-
13
-
-
0028071051
-
Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2)
-
DOI 10.1023/A:1018967116988
-
Artursson, P., Lindmark, T., Davis, S.S., Illum, L., 1994. Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2). Pharm. Res. 11, 1358-1361. (Pubitemid 24287420)
-
(1994)
Pharmaceutical Research
, vol.11
, Issue.9
, pp. 1358-1361
-
-
Artursson, P.1
Lindmark, T.2
Davis, S.S.3
Illum, L.4
-
14
-
-
0030704614
-
The leishmaniases as model zoonoses
-
DOI 10.1080/00034989760428
-
Ashford, R.W., 1997. The leishmaniases as model zoonoses. Ann. Trop. Med. Parasitol. 91, 693-701. (Pubitemid 27480434)
-
(1997)
Annals of Tropical Medicine and Parasitology
, vol.91
, Issue.7
, pp. 693-701
-
-
Ashford, R.W.1
-
15
-
-
33847219040
-
Molecular mechanisms of antimony resistance in leishmania
-
Ashutosh Sundar, S., Goyal, N., 2007. Molecular mechanisms of antimony resistance in leishmania. J. Med. Microbiol. 56, 143-153.
-
(2007)
J. Med. Microbiol.
, vol.56
, pp. 143-153
-
-
Ashutosh Sundar, S.1
Goyal, N.2
-
16
-
-
84875148599
-
Immunoadjuvant chemotherapy of visceral leishmaniasis in hamsters using amphotericin B encapsulated nano-emulsion template based chitosan nanocapsules
-
Asthana, S., Jaiswal, A.K., Gupta, P.K., Pawar, V.K., Dube, A., Chourasia, M.K., 2013. Immunoadjuvant chemotherapy of visceral leishmaniasis in hamsters using amphotericin B encapsulated nano-emulsion template based chitosan nanocapsules. Antimicrob. Agents Chemother. 57, 1714-1722.
-
(2013)
Antimicrob. Agents Chemother.
, vol.57
, pp. 1714-1722
-
-
Asthana, S.1
Jaiswal, A.K.2
Gupta, P.K.3
Pawar, V.K.4
Dube, A.5
Chourasia, M.K.6
-
17
-
-
0032053990
-
The pharmacology of leishmaniasis
-
DOI 10.1016/S0306-3623(97)00268-1, PII S0306362397002681
-
Balaña-Fouce, R., Reguera, R.M., Cubría, J.C., Ordóñez, D., 1998. The pharmacology of leishmaniasis. Gen. Pharmacol. Vasc. Syst. 30, 435-443. (Pubitemid 28102818)
-
(1998)
General Pharmacology
, vol.30
, Issue.4
, pp. 435-443
-
-
Balana-Fouce, R.1
Reguera, R.M.2
Cubria, J.C.3
Ordonez, D.4
-
18
-
-
84870410906
-
Liposomal amphotericin B as a treatment for human leishmaniasis
-
Balasegaram, M., Ritmeijer, K., Lima, M.A., Burza, S., Ortiz Genovese, G., Milani, B., Gaspani, S., Potet, J., Chappuis, F., 2012. Liposomal amphotericin B as a treatment for human leishmaniasis. Expert Opin. Emerg. Drugs 17, 493-510.
-
(2012)
Expert Opin. Emerg. Drugs
, vol.17
, pp. 493-510
-
-
Balasegaram, M.1
Ritmeijer, K.2
Lima, M.A.3
Burza, S.4
Ortiz Genovese, G.5
Milani, B.6
Gaspani, S.7
Potet, J.8
Chappuis, F.9
-
19
-
-
0030179394
-
Drug delivery system: Targeting of pentamidines to specific sites using sugar grafted liposomes
-
Banerjee, G., Nandi, G., Mahato, S.B., Pakrashi, A., Basu, M.K., 1996. Drug delivery system: targeting of pentamidines to specific sites using sugar grafted liposomes. J. Antimicrob. Chemother. 38, 145-150. (Pubitemid 126449219)
-
(1996)
Journal of Antimicrobial Chemotherapy
, vol.38
, Issue.1
, pp. 145-150
-
-
Banerjee, G.1
Nandi, G.2
Mahato, S.B.3
Pakrashi, A.4
Basu, M.K.5
-
20
-
-
70350787689
-
Optimizing efficacy of Amphotericin B through nanomodification
-
Barratt, G., Bretagne, S., 2007. Optimizing efficacy of amphotericin B through nanomodification. Int. J. Nanomed. 2, 301-313. (Pubitemid 350047775)
-
(2007)
International Journal of Nanomedicine
, vol.2
, Issue.3
, pp. 301-313
-
-
Barratt, G.1
Bretagne, S.2
-
21
-
-
0036894232
-
Resistance to pentamidine in Leishmania mexicana involves exclusion of the drug from the mitochondrion
-
DOI 10.1128/AAC.46.12.3731-3738.2002
-
Basselin, M., Denise, H., Coombs, G.H., Barrett, M.P., 2002. Resistance to pentamidine in Leishmania mexicana involves exclusion of the drug from the mitochondrion. Antimicrob. Agents Chemother. 46, 3731-3738. (Pubitemid 35403244)
-
(2002)
Antimicrobial Agents and Chemotherapy
, vol.46
, Issue.12
, pp. 3731-3738
-
-
Basselin, M.1
Denise, H.2
Coombs, G.H.3
Barrett, M.P.4
-
22
-
-
4444272379
-
Macrophage specific drug delivery in experimental leishmaniasis
-
DOI 10.2174/1566524043360186
-
Basu, M.K., Lala, S., 2004. Macrophage specific drug delivery in experimental leishmaniasis. Curr. Mol. Med. 4, 681-689. (Pubitemid 39172370)
-
(2004)
Current Molecular Medicine
, vol.4
, Issue.6
, pp. 681-689
-
-
Basu, M.K.1
Lala, S.2
-
23
-
-
0025914360
-
Cyclodextrins in the pharmaceutical field
-
Bekers, O., Uijtendaal, E.V., Beijnen, J.H., Bult, A., Underberg, W.J.M., 1991. Cyclodextrins in the pharmaceutical field. Drug Dev. Ind. Pharm. 17, 1503-1549.
-
(1991)
Drug Dev. Ind. Pharm.
, vol.17
, pp. 1503-1549
-
-
Bekers, O.1
Uijtendaal, E.V.2
Beijnen, J.H.3
Bult, A.4
Underberg, W.J.M.5
-
24
-
-
84884136700
-
-
American Society for Microbiology, Washington, DC, ETATSUNIS
-
Berman, J., Ksionski, D., Chapman, G.W., Waits, L.V., Hanson, B.W.L., 1992. Activity of Amphotericin B Cholesterol Dispersion (Amphocil) in Experimental Visceral Leishmaniasis. American Society for Microbiology, Washington, DC, ETATSUNIS.
-
(1992)
Activity of Amphotericin B Cholesterol Dispersion (Amphocil) in Experimental Visceral Leishmaniasis
-
-
Berman, J.1
Ksionski, D.2
Chapman, G.W.3
Waits, L.V.4
Hanson, B.W.L.5
-
25
-
-
13544254608
-
Recent developments in leishmaniasis: Epidemiology, diagnosis, and treatment
-
Berman, J., 2005. Recent developments in leishmaniasis: epidemiology, diagnosis, and treatment. Curr. Infect. Dis. Rep. 7, 33-38. (Pubitemid 40220526)
-
(2005)
Current Infectious Disease Reports
, vol.7
, Issue.1
, pp. 33-38
-
-
Berman, J.1
-
26
-
-
0024004690
-
Chemotherapy for leishmaniasis: Biochemical mechanisms, clinical efficacy, and future strategies
-
Berman, J.D., 1988. Chemotherapy for leishmaniasis: biochemical mechanisms, clinical efficacy, and future strategies. Rev. Infect. Dis. 10, 560-586.
-
(1988)
Rev. Infect. Dis.
, vol.10
, pp. 560-586
-
-
Berman, J.D.1
-
27
-
-
0030940539
-
Human leishmaniasis: Clinical, diagnostic, and chemotherapeutic developments in the last 10 years
-
Berman, J.D., 1997. Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin. Infect. Dis. 24, 684-703. (Pubitemid 27143564)
-
(1997)
Clinical Infectious Diseases
, vol.24
, Issue.4
, pp. 684-703
-
-
Berman, J.D.1
-
28
-
-
17544387144
-
Efficacy and safety of liposomal amphotericin B (AmBisome) for visceral leishmaniasis in endemic developing countries
-
Berman, J.D., Badaro, R., Thakur, C.P., Wasunna, K.M., Behbehani, K., Davidson, R., Kuzoe, F., Pang, L., Weerasuriya, K., Bryceson, A.D., 1998. Efficacy and safety of liposomal amphotericin B (AmBisome) for visceral leishmaniasis in endemic developing countries. Bull. World Health Organ. 76, 25-32. (Pubitemid 28254976)
-
(1998)
Bulletin of the World Health Organization
, vol.76
, Issue.1
, pp. 25-32
-
-
Berman, J.D.1
Badaro, R.2
Thakur, C.P.3
Wasunna, K.M.4
Behbehani, K.5
Davidson, R.6
Kuzoe, F.7
Pang, L.8
Weerasuriya, K.9
Bryceson, A.D.M.10
-
29
-
-
0023002487
-
Antileishmanial activity of liposome-encapsulated amphotericin B in hamsters and monkeys
-
Berman, J.D., Hanson, W.L., Chapman, W.L., Alving, C.R., Lopez-Berestein, G., 1986. Antileishmanial activity of liposome-encapsulated amphotericin B in hamsters and monkeys. Antimicrob. Agents Chemother. 30, 847-851.
-
(1986)
Antimicrob. Agents Chemother.
, vol.30
, pp. 847-851
-
-
Berman, J.D.1
Hanson, W.L.2
Chapman, W.L.3
Alving, C.R.4
Lopez-Berestein, G.5
-
30
-
-
33748647413
-
Liposomal amphotericin B for the treatment of visceral leishmaniasis
-
DOI 10.1086/507530
-
Bern, C., Adler-Moore, J., Berenguer, J., Boelaert, M., den Boer, M., Davidson, R.N., Figueras, C., Gradoni, L., Kafetzis, D.A., Ritmeijer, K., Rosenthal, E., Royce, C., Russo, R., Sundar, S., Alvar, J., 2006. Liposomal amphotericin B for the treatment of visceral leishmaniasis. Clin. Infect. Dis. 43, 917-924. (Pubitemid 44435523)
-
(2006)
Clinical Infectious Diseases
, vol.43
, Issue.7
, pp. 917-924
-
-
Bern, C.1
Adler-Moore, J.2
Berenguer, J.3
Boelaert, M.4
Den, B.M.5
Davidson, R.N.6
Figueras, C.7
Gradoni, L.8
Kafetzis, D.A.9
Ritmeijer, K.10
Rosenthal, E.11
Royce, C.12
Russo, R.13
Sundar, S.14
Alvar, J.15
-
31
-
-
84876161904
-
Nanocarrier systems for oral drug delivery: Do we really need them?
-
Bernkop-Schnürch, A., 2013. Nanocarrier systems for oral drug delivery: do we really need them? Eur. J. Pharm. Sci. 49, 272-277.
-
(2013)
Eur. J. Pharm. Sci.
, vol.49
, pp. 272-277
-
-
Bernkop-Schnürch, A.1
-
32
-
-
0033790205
-
Visceral leishmaniasis control: A public health perspective
-
Boelaert, M., Criel, B., Leeuwenburg, J., Van Damme, W., Le Ray, D., Van der Stuyft, P., 2000. Visceral leishmaniasis control: a public health perspective. Trans. R. Soc. Trop. Med. Hyg. 94, 465-471.
-
(2000)
Trans. R. Soc. Trop. Med. Hyg.
, vol.94
, pp. 465-471
-
-
Boelaert, M.1
Criel, B.2
Leeuwenburg, J.3
Van Damme, W.4
Le Ray, D.5
Van Der Stuyft, P.6
-
33
-
-
0022862167
-
How do the polyene macrolide antibiotics affect the cellular membrane properties?
-
Bolard, J., 1986. How do the polyene macrolide antibiotics affect the cellular membrane properties? Biochim. Biophys. Acta 864, 257-304. (Pubitemid 17228111)
-
(1986)
Biochimica et Biophysica Acta - Reviews on Biomembranes
, vol.864
, Issue.3-4
, pp. 257-304
-
-
Bolard, J.1
-
34
-
-
0033093302
-
Epidemiology of visceral leishmaniasis in India
-
Bora, D., 1999. Epidemiology of visceral leishmaniasis in India. Natl. Med. J. India 12, 62-68.
-
(1999)
Natl. Med. J. India
, vol.12
, pp. 62-68
-
-
Bora, D.1
-
35
-
-
40749149204
-
Selection and phenotype characterisation of sitamaquine-resistant promastigotes of Leishmania donovani
-
DOI 10.1016/j.biopha.2007.12.006, PII S0753332207002892
-
Bories, C., Cojean, S., Huteau, F., Loiseau, P.M., 2008. Selection and phenotype characterisation of sitamaquine-resistant promastigotes of Leishmania donovani. Biomed. Pharmacother. 62, 164-167. (Pubitemid 351381937)
-
(2008)
Biomedicine and Pharmacotherapy
, vol.62
, Issue.3
, pp. 164-167
-
-
Bories, C.1
Cojean, S.2
Huteau, F.3
Loiseau, P.M.4
-
36
-
-
31144457181
-
Lyotropic liquid crystalline phases formed from glycerate surfactants as sustained release drug delivery systems
-
DOI 10.1016/j.ijpharm.2005.11.033, PII S0378517305008069
-
Boyd, B.J., Whittaker, D.V., Khoo, S.M., Davey, G., 2006. Lyotropic liquid crystalline phases formed from glycerate surfactants as sustained release drug delivery systems. Int. J. Pharm. 309, 218-226. (Pubitemid 43129485)
-
(2006)
International Journal of Pharmaceutics
, vol.309
, Issue.1-2
, pp. 218-226
-
-
Boyd, B.J.1
Whittaker, D.V.2
Khoo, S.-M.3
Davey, G.4
-
37
-
-
0025139028
-
Amphotericin B: Delivery systems
-
Brajtburg, J., Powderly, W.G., Kobayashi, G.S., Medoff, G., 1990. Amphotericin B: delivery systems. Antimicrob. Agents Chemother. 34, 381-384. (Pubitemid 20068656)
-
(1990)
Antimicrobial Agents and Chemotherapy
, vol.34
, Issue.3
, pp. 381-384
-
-
Brajtburg, J.1
Powderly, W.G.2
Kobayashi, G.S.3
Medoff, G.4
-
38
-
-
0038742717
-
Pentamidine uptake and resistance in pathogenic protozoa: Past, present and future
-
DOI 10.1016/S1471-4922(03)00069-2
-
Bray, P.G., Barrett, M.P., Ward, S.A., de Koning, H.P., 2003. Pentamidine uptake and resistance in pathogenic protozoa: past, present and future. Trends Parasitol. 19, 232-239. (Pubitemid 36588598)
-
(2003)
Trends in Parasitology
, vol.19
, Issue.5
, pp. 232-239
-
-
Bray, P.G.1
Barrett, M.P.2
Ward, S.A.3
De Koning, H.P.4
-
39
-
-
0035161541
-
Current issues in the treatment of visceral leishmaniasis
-
Bryceson, A., 2001a. Current issues in the treatment of visceral leishmaniasis. Med. Microbiol. Immunol. 190, 81-84. (Pubitemid 33079365)
-
(2001)
Medical Microbiology and Immunology
, vol.190
, Issue.1-2
, pp. 81-84
-
-
Bryceson, A.1
-
40
-
-
0034772197
-
A policy for leishmaniasis with respect to the prevention and control of drug resistance
-
DOI 10.1046/j.1365-3156.2001.00795.x
-
Bryceson, A., 2001b. A policy for leishmaniasis with respect to the prevention and control of drug resistance. Trop. Med. Int. Health 6, 928-934. (Pubitemid 33010880)
-
(2001)
Tropical Medicine and International Health
, vol.6
, Issue.11
, pp. 928-934
-
-
Bryceson, A.1
-
41
-
-
80051817554
-
The 8-aminoquinoline analogue sitamaquine causes oxidative stress in Leishmania donovani promastigotes by targeting succinate dehydrogenase
-
Carvalho, L., Luque-Ortega, J.R., Lopez-Martin, C., Castanys, S., Rivas, L., Gamarro, F., 2011. The 8-aminoquinoline analogue sitamaquine causes oxidative stress in Leishmania donovani promastigotes by targeting succinate dehydrogenase. Antimicrob. Agents Chemother. 55, 4204-4210.
-
(2011)
Antimicrob. Agents Chemother.
, vol.55
, pp. 4204-4210
-
-
Carvalho, L.1
Luque-Ortega, J.R.2
Lopez-Martin, C.3
Castanys, S.4
Rivas, L.5
Gamarro, F.6
-
42
-
-
0035543633
-
Plant natural products with leishmanicidal activity
-
DOI 10.1039/b100455g
-
Chan-Bacab, M.J., Pena-Rodriguez, L.M., 2001. Plant natural products with leishmanicidal activity. Nat. Prod. Rep. 18, 674-688. (Pubitemid 34010018)
-
(2001)
Natural Product Reports
, vol.18
, Issue.6
, pp. 674-688
-
-
Chan-Bacab, M.J.1
Pena-Rodriguez, L.M.2
-
43
-
-
0021278727
-
Antileishmanial activity of liposome-encapsulated meglumine antimonate in the dog
-
Chapman Jr., W.L., Hanson, W.L., Alving, C.R., Hendricks, L.D., 1984. Antileishmanial activity of liposome-encapsulated meglumine antimonate in the dog. Am. J. Vet. Res. 45, 1028-1030. (Pubitemid 14113845)
-
(1984)
American Journal of Veterinary Research
, vol.45
, Issue.5
, pp. 1028-1030
-
-
Chapman Jr., W.L.1
Hanson, W.L.2
Alving, C.R.3
Hendricks, L.D.4
-
44
-
-
35548987998
-
Visceral leishmaniasis: What are the needs for diagnosis, treatment and control?
-
DOI 10.1038/nrmicro1748, PII NRMICRO1748
-
Chappuis, F., Sundar, S., Hailu, A., Ghalib, H., Rijal, S., Peeling, R.W., Alvar, J., Boelaert, M., 2007. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat. Rev. Microbiol. 5, 873-882. (Pubitemid 47578388)
-
(2007)
Nature Reviews Microbiology
, vol.5
, Issue.11
, pp. 873-882
-
-
Chappuis, F.1
Sundar, S.2
Hailu, A.3
Ghalib, H.4
Rijal, S.5
Peeling, R.W.6
Alvar, J.7
Boelaert, M.8
-
45
-
-
0036211404
-
Self-assembled nanocubicle as a carrier for peroral insulin delivery
-
DOI 10.1007/s00125-001-0751-z
-
Chung, H., Kim, J., Um, J.Y., Kwon, I.C., Jeong, S.Y., 2002. Self-assembled nanocubicle as a carrier for peroral insulin delivery. Diabetologia 45, 448-451. (Pubitemid 34267369)
-
(2002)
Diabetologia
, vol.45
, Issue.3
, pp. 448-451
-
-
Chung, H.1
Kim, J.2
Um, J.Y.3
Kwon, I.C.4
Jeong, S.Y.5
-
46
-
-
84858649702
-
Leishmania resistance to miltefosine associated with genetic marker
-
Cojean, S., Houze, S., Haouchine, D., Huteau, F., Lariven, S., Hubert, V., Michard, F., Bories, C., Pratlong, F., Le Bras, J., Loiseau, P.M., Matheron, S., 2012. Leishmania resistance to miltefosine associated with genetic marker. Emerg. Infect. Dis. 18, 704-706.
-
(2012)
Emerg. Infect. Dis.
, vol.18
, pp. 704-706
-
-
Cojean, S.1
Houze, S.2
Haouchine, D.3
Huteau, F.4
Lariven, S.5
Hubert, V.6
Michard, F.7
Bories, C.8
Pratlong, F.9
Le Bras, J.10
Loiseau, P.M.11
Matheron, S.12
-
47
-
-
0027590737
-
Nano- and microparticles for the delivery of polypeptides and proteins
-
Couvreur, P., Puisieux, F., 1993. Nano- and microparticles for the delivery of polypeptides and proteins. Adv. Drug Deliv. Rev. 10, 141-162. (Pubitemid 23172580)
-
(1993)
Advanced Drug Delivery Reviews
, vol.10
, Issue.2-3
, pp. 141-162
-
-
Couvreur, P.1
Puisieux, F.2
-
48
-
-
0017730504
-
Nanocapsules: A new type of lysosomotropic carrier
-
DOI 10.1016/0014-5793(77)80717-5
-
Couvreur, P., Tulkens, P., Roland, M., Trouet, A., Speiser, P., 1977. Nanocapsules: a new type of lysosomotropic carrier. FEBS Lett. 84, 323-326. (Pubitemid 8246984)
-
(1977)
FEBS Letters
, vol.84
, Issue.2
, pp. 323-326
-
-
Couvreur, P.1
Tulkens, P.2
Roland, M.3
-
49
-
-
0142258171
-
Leishmaniasis - Current chemotherapy and recent advances in the search for novel drugs
-
DOI 10.1016/j.pt.2003.09.008
-
Croft, S.L., Coombs, G.H., 2003. Leishmaniasis - current chemotherapy and recent advances in the search for novel drugs. Trends Parasitol. 19, 502-508. (Pubitemid 37329659)
-
(2003)
Trends in Parasitology
, vol.19
, Issue.11
, pp. 502-508
-
-
Croft, S.L.1
Coombs, G.H.2
-
50
-
-
0023186694
-
The activity of alkyl phosphorylcholines and related derivatives against Leishmania donovani
-
DOI 10.1016/0006-2952(87)90543-0
-
Croft, S.L., Neal, R.A., Pendergast, W., Chan, J.H., 1987. The activity of alkyl phosphorylcholines and related derivatives against Leishmania donovani. Biochem. Pharmacol. 36, 2633-2636. (Pubitemid 17102920)
-
(1987)
Biochemical Pharmacology
, vol.36
, Issue.16
, pp. 2633-2636
-
-
Croft, S.L.1
Neal, R.A.2
Pendergast, W.3
Chan, J.H.4
-
51
-
-
31544439919
-
Drug resistance in leishmaniasis
-
DOI 10.1128/CMR.19.1.111-126.2006
-
Croft, S.L., Sundar, S., Fairlamb, A.H., 2006. Drug resistance in leishmaniasis. Clin. Microbiol. Rev. 19, 111-126. (Pubitemid 43157649)
-
(2006)
Clinical Microbiology Reviews
, vol.19
, Issue.1
, pp. 111-126
-
-
Croft, S.L.1
Sundar, S.2
Fairlamb, A.H.3
-
52
-
-
0031809090
-
Effect of various lipid-bile salt mixed micelles on the intestinal absorption of amphotericin-B in rat
-
Dangi, J.S., Vyas, S.P., Dixit, V.K., 1998. Effect of various lipid-bile salt mixed micelles on the intestinal absorption of amphotericin-B in rat. Drug Dev. Ind. Pharm. 24, 631-635. (Pubitemid 28312300)
-
(1998)
Drug Development and Industrial Pharmacy
, vol.24
, Issue.7
, pp. 631-635
-
-
Dangi, J.S.1
Vyas, S.P.2
Dixit, V.K.3
-
53
-
-
0032438513
-
Practical guide for the treatment of leishmaniasis
-
DOI 10.2165/00003495-199856060-00005
-
Davidson, R.N., 1998. Practical guide for the treatment of leishmaniasis. Drugs 56, 1009-1018. (Pubitemid 29010219)
-
(1998)
Drugs
, vol.56
, Issue.6
, pp. 1009-1018
-
-
Davidson, R.N.1
-
54
-
-
0025872527
-
Liposomal amphotericin B in drug-resistant visceral leishmaniasis
-
Davidson, R.N., Scott, A., Maini, M., Bryceson, A.D.M., Croft, S.L., 1991. Liposomal amphotericin B in drug-resistant visceral leishmaniasis. Lancet 337, 1061-1062.
-
(1991)
Lancet
, vol.337
, pp. 1061-1062
-
-
Davidson, R.N.1
Scott, A.2
Maini, M.3
Bryceson, A.D.M.4
Croft, S.L.5
-
55
-
-
0035992021
-
Efficacy of orally delivered cochleates containing amphotericin B in a murine model of aspergillosis
-
DOI 10.1128/AAC.46.8.2704-2707.2002
-
Delmas, G., Park, S., Chen, Z.W., Tan, F., Kashiwazaki, R., Zarif, L., Perlin, D.S., 2002. Efficacy of orally delivered cochleates containing amphotericin B in a murine model of aspergillosis. Antimicrob. Agents Chemother. 46, 2704-2707. (Pubitemid 34793493)
-
(2002)
Antimicrobial Agents and Chemotherapy
, vol.46
, Issue.8
, pp. 2704-2707
-
-
Delmas, G.1
Park, S.2
Chen, Z.W.3
Tan, F.4
Kashiwazaki, R.5
Zarif, L.6
Perlin, D.S.7
-
56
-
-
0347361714
-
Oral Delivery of Meglumine Antimoniate-beta-Cyclodextrin Complex for Treatment of Leishmaniasis
-
DOI 10.1128/AAC.48.1.100-103.2004
-
Demicheli, C., Ochoa, R., da Silva, J.B., Falcao, C.A., Rossi-Bergmann, B., de Melo, A.L., Sinisterra, R.D., Frezard, F., 2004. Oral delivery of meglumine antimoniatebeta-cyclodextrin complex for treatment of leishmaniasis. Antimicrob. Agents Chemother. 48, 100-103. (Pubitemid 38040183)
-
(2004)
Antimicrobial Agents and Chemotherapy
, vol.48
, Issue.1
, pp. 100-103
-
-
Demicheli, C.1
Ochoa, R.2
Da, S.J.B.B.3
Falcao, C.A.B.4
Rossi-Bergmann, B.5
De Melo, A.L.6
Sinisterra, R.D.7
Frezard, F.8
-
57
-
-
0033193097
-
Combination allopurinol and antimony treatment versus antimony alone and allopurinol alone in the treatment of canine leishmaniasis (96 cases)
-
Denerolle, P., Bourdoiseau, G., 1999. Combination allopurinol and antimony treatment versus antimony alone and allopurinol alone in the treatment of canine leishmaniasis (96 cases). J. Vet. Intern. Med. 13, 413-415.
-
(1999)
J. Vet. Intern. Med.
, vol.13
, pp. 413-415
-
-
Denerolle, P.1
Bourdoiseau, G.2
-
58
-
-
0030249268
-
Leishmaniasis: Public health aspects and control
-
DOI 10.1016/0738-081X(96)00057-0
-
Desjeux, P., 1996. Leishmaniasis: public health aspects and control. Clin. Dermatol. 14, 417-423. (Pubitemid 26327735)
-
(1996)
Clinics in Dermatology
, vol.14
, Issue.5
, pp. 417-423
-
-
Desjeux, P.1
-
59
-
-
0014437227
-
Nephrotoxic effects of amphotericin B, including renal tubular acidosis
-
Douglas, J.B., Healy, J.K., 1969. Nephrotoxic effects of amphotericin B, including renal tubular acidosis. Am. J. Med. 46, 154-162.
-
(1969)
Am. J. Med.
, vol.46
, pp. 154-162
-
-
Douglas, J.B.1
Healy, J.K.2
-
60
-
-
60449087425
-
Preparation and characteristics of linoleic acid-grafted chitosan oligosaccharide micelles as a carrier for doxorubicin
-
Du, Y.Z., Wang, L., Yuan, H., Wei, X.H., Hu, F.Q., 2009. Preparation and characteristics of linoleic acid-grafted chitosan oligosaccharide micelles as a carrier for doxorubicin. Colloids Surf. B: Biointerfaces 69, 257-263.
-
(2009)
Colloids Surf. B: Biointerfaces
, vol.69
, pp. 257-263
-
-
Du, Y.Z.1
Wang, L.2
Yuan, H.3
Wei, X.H.4
Hu, F.Q.5
-
61
-
-
33846410660
-
Interaction of sitamaquine with membrane lipids of Leishmania donovani promastigotes
-
DOI 10.1016/j.bbamem.2006.07.003, PII S0005273606002628
-
Dueñas-Romero, A.M., Loiseau, P.M., Saint-Pierre-Chazalet, M., 2007. Interaction of sitamaquine with membrane lipids of Leishmania donovani promastigotes. Biochim. Biophys. Acta (BBA): Biomembr. 1768, 246-252. (Pubitemid 46138097)
-
(2007)
Biochimica et Biophysica Acta - Biomembranes
, vol.1768
, Issue.2
, pp. 246-252
-
-
Duenas-Romero, A.M.1
Loiseau, P.M.2
Saint-Pierre-Chazalet, M.3
-
62
-
-
84856544817
-
Tocol modified glycol chitosan for the oral delivery of poorly soluble drugs
-
Duhem, N., Rolland, J., Riva, R., Guillet, P., Schumers, J.-M., Jérome, C., Gohy, J.-F., Préat, V., 2012. Tocol modified glycol chitosan for the oral delivery of poorly soluble drugs. Int. J. Pharm. 423, 452-460.
-
(2012)
Int. J. Pharm.
, vol.423
, pp. 452-460
-
-
Duhem, N.1
Rolland, J.2
Riva, R.3
Guillet, P.4
Schumers, J.-M.5
Jérome, C.6
Gohy, J.-F.7
Préat, V.8
-
63
-
-
0036968374
-
In vitro antileishmanial activity of amphotericin B loaded in poly(epsiloncaprolactone) nanospheres
-
Espuelas, M.S., Legrand, P., Loiseau, P.M., Bories, C., Barratt, G., Irache, J.M., 2002. In vitro antileishmanial activity of amphotericin B loaded in poly(epsiloncaprolactone) nanospheres. J. Drug Target. 10, 593-599.
-
(2002)
J. Drug Target.
, vol.10
, pp. 593-599
-
-
Espuelas, M.S.1
Legrand, P.2
Loiseau, P.M.3
Bories, C.4
Barratt, G.5
Irache, J.M.6
-
64
-
-
0036833567
-
Natural products as trypanocidal, antileishmanial and antimalarial drugs
-
Fournet, A., Munoz, V., 2002. Natural products as trypanocidal, antileishmanial and antimalarial drugs. Curr. Top. Med. Chem. 2, 1215-1237.
-
(2002)
Curr. Top. Med. Chem.
, vol.2
, pp. 1215-1237
-
-
Fournet, A.1
Munoz, V.2
-
65
-
-
68649102607
-
Pentavalent antimonials: New perspectives for old drugs
-
Frézard, F., Demicheli, C., Ribeiro, R., 2009. Pentavalent antimonials: new perspectives for old drugs. Molecules 14, 2317-2336.
-
(2009)
Molecules
, vol.14
, pp. 2317-2336
-
-
Frézard, F.1
Demicheli, C.2
Ribeiro, R.3
-
66
-
-
36549015687
-
Enhanced oral delivery of antimony from meglumine antimoniate/beta- cyclodextrin nanoassemblies
-
DOI 10.1016/j.ijpharm.2007.06.029, PII S0378517307005200
-
Frezard, F., Martins, P.S., Bahia, A.P., Le Moyec, L., de Melo, A.L., Pimenta, A.M., Salerno, M., da Silva, J.B., Demicheli, C., 2008. Enhanced oral delivery of antimony from meglumine antimoniate/beta-cyclodextrin nanoassemblies. Int. J. Pharm. 347, 102-108. (Pubitemid 350186086)
-
(2008)
International Journal of Pharmaceutics
, vol.347
, Issue.1-2
, pp. 102-108
-
-
Frezard, F.1
Martins, P.S.2
Bahia, A.P.C.O.3
Le, M.L.4
De Melo, A.L.5
Pimenta, A.M.C.6
Salerno, M.7
Silva, J.B.B.D.8
Demicheli, C.9
-
67
-
-
0026507069
-
Drug targeting with polyalkylcyanoacrylate nanoparticles: In vitro activity of primaquine-loaded nanoparticles against intracellular Leishmania donovani
-
Gaspar, R., Opperdoes, F.R., Preat, V., Roland, M., 1992. Drug targeting with polyalkylcyanoacrylate nanoparticles: in vitro activity of primaquine-loaded nanoparticles against intracellular Leishmania donovani. Ann. Trop. Med. Parasitol. 86, 41-49.
-
(1992)
Ann. Trop. Med. Parasitol.
, vol.86
, pp. 41-49
-
-
Gaspar, R.1
Opperdoes, F.R.2
Preat, V.3
Roland, M.4
-
68
-
-
78149474474
-
Biodistribution and tissue toxicity of amphotericin B in mice following multiple dose administration of a novel oral lipid-based formulation (iCo-009)
-
Gershkovich, P., Sivak, O., Wasan, E.K., Magil, A.B., Owen, D., Clement, J.G., Wasan, K.M., 2010. Biodistribution and tissue toxicity of amphotericin B in mice following multiple dose administration of a novel oral lipid-based formulation (iCo-009). J. Antimicrob. Chemother. 65, 2610-2613.
-
(2010)
J. Antimicrob. Chemother.
, vol.65
, pp. 2610-2613
-
-
Gershkovich, P.1
Sivak, O.2
Wasan, E.K.3
Magil, A.B.4
Owen, D.5
Clement, J.G.6
Wasan, K.M.7
-
69
-
-
67249101874
-
Pharmacokinetics and biodistribution of amphotericin B in rats following oral administration in a novel lipid-based formulation
-
Gershkovich, P., Wasan, E.K., Lin, M., Sivak, O., Leon, C.G., Clement, J.G., Wasan, K.M., 2009. Pharmacokinetics and biodistribution of amphotericin B in rats following oral administration in a novel lipid-based formulation. J. Antimicrob. Chemother. 64, 101-108.
-
(2009)
J. Antimicrob. Chemother.
, vol.64
, pp. 101-108
-
-
Gershkovich, P.1
Wasan, E.K.2
Lin, M.3
Sivak, O.4
Leon, C.G.5
Clement, J.G.6
Wasan, K.M.7
-
70
-
-
78650061557
-
Development of respirable nanomicelle carriers for delivery of amphotericin B by jet nebulization
-
Gilani, K., Moazeni, E., Ramezanli, T., Amini, M., Fazeli, M.R., Jamalifar, H., 2011. Development of respirable nanomicelle carriers for delivery of amphotericin B by jet nebulization. J. Pharm. Sci. 100, 252-259.
-
(2011)
J. Pharm. Sci.
, vol.100
, pp. 252-259
-
-
Gilani, K.1
Moazeni, E.2
Ramezanli, T.3
Amini, M.4
Fazeli, M.R.5
Jamalifar, H.6
-
71
-
-
0032085984
-
Use of allopurinol for maintenance of remission in dogs with leishmaniasis
-
Ginel, P.J., Lucena, R., Lopez, R., Molleda, J.M., 1998. Use of allopurinol for maintenance of remission in dogs with leishmaniasis. J. Small Anim. Pract. 39, 271-274. (Pubitemid 128527594)
-
(1998)
Journal of Small Animal Practice
, vol.39
, Issue.6
, pp. 271-274
-
-
Ginel, P.J.1
Lucena, R.2
Lopez, R.3
Molleda, J.M.4
-
72
-
-
85076867225
-
Modified chitosan hydrogels as drug delivery and tissue engineering systems: Present status and applications
-
Giri, T.K., Thakur, A., Alexander, A., Ajazuddin Badwaik, H., Tripathi, D.K., 2012. Modified chitosan hydrogels as drug delivery and tissue engineering systems: present status and applications. Acta Pharm. Sin. B 2, 439-449.
-
(2012)
Acta Pharm. Sin. B
, vol.2
, pp. 439-449
-
-
Giri, T.K.1
Thakur, A.2
Alexander, A.3
Ajazuddin Badwaik, H.4
Tripathi, D.K.5
-
73
-
-
0023935436
-
Effect of the aggregation state of amphotericin B on its interaction with ergosterol
-
Gruda, I., Dussault, N., 1988. Effect of the aggregation state of amphotericin B on its interaction with ergosterol. Biochem. Cell Biol. 66, 177-183.
-
(1988)
Biochem. Cell Biol.
, vol.66
, pp. 177-183
-
-
Gruda, I.1
Dussault, N.2
-
74
-
-
0036319712
-
Visceral leishmaniasis: Current status of control, diagnosis, and treatment, and a proposed research and development agenda
-
DOI 10.1016/S1473-3099(02)00347-X
-
Guerin, P.J., Olliaro, P., Sundar, S., Boelaert, M., Croft, S.L., Desjeux, P., Wasunna, M.K., Bryceson, A.D.M., 2002. Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. Lancet Infect. Dis. 2, 494-501. (Pubitemid 34826855)
-
(2002)
Lancet Infectious Diseases
, vol.2
, Issue.8
, pp. 494-501
-
-
Guerin, P.J.1
Olliaro, P.2
Sundar, S.3
Boelaert, M.4
Croft, S.L.5
Desjeux, P.6
Wasunna, M.K.7
Bryceson, A.D.M.8
-
75
-
-
77749283311
-
Drug delivery strategies for therapy of visceral leishmaniasis
-
Gupta, S., Pal, A., Vyas, S.P., 2010. Drug delivery strategies for therapy of visceral leishmaniasis. Expert Opin. Drug Deliv. 7, 371-402.
-
(2010)
Expert Opin. Drug Deliv.
, vol.7
, pp. 371-402
-
-
Gupta, S.1
Pal, A.2
Vyas, S.P.3
-
76
-
-
84965094146
-
An evaluation of amphotericin B in vitro and in vivo in mice against Coccidioides immitis and Candida albicans, and preliminary observations concerning the administration of amphotericin B to man
-
discussion 231-212
-
Halde, C., Newcomer, V.D., Wright, E.T., Sternberg, T.H., 1957. An evaluation of amphotericin B in vitro and in vivo in mice against Coccidioides immitis and Candida albicans, and preliminary observations concerning the administration of amphotericin B to man. J. Invest. Dermatol. 28, 217-231 (discussion 231-212).
-
(1957)
J. Invest. Dermatol.
, vol.28
, pp. 217-231
-
-
Halde, C.1
Newcomer, V.D.2
Wright, E.T.3
Sternberg, T.H.4
-
77
-
-
0030449320
-
Amphotericin B: New life for an old drug
-
DOI 10.1016/S0165-6147(96)01012-7
-
Hartsel, S., Bolard, J., 1996. Amphotericin B: new life for an old drug. Trends Pharmacol. Sci. 17, 445-449. (Pubitemid 27028476)
-
(1996)
Trends in Pharmacological Sciences
, vol.17
, Issue.12
, pp. 445-449
-
-
Hartsel, S.1
Bolard, J.2
-
78
-
-
0031914282
-
Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor
-
Hauss, D.J., Fogal, S.E., Ficorilli, J.V., Price, C.A., Roy, T., Jayaraj, A.A., Keirns, J.J., 1998. Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor. J. Pharm. Sci. 87, 164-169.
-
(1998)
J. Pharm. Sci.
, vol.87
, pp. 164-169
-
-
Hauss, D.J.1
Fogal, S.E.2
Ficorilli, J.V.3
Price, C.A.4
Roy, T.5
Jayaraj, A.A.6
Keirns, J.J.7
-
79
-
-
0021179518
-
Quantitative and ultrastructural studies on the uptake of drug loaded liposomes by mononuclear phagocytes infected with Leishmania donovani
-
Heath, S., Chance, M.L., New, R.R.C., 1984. Quantitative and ultrastructural studies on the uptake of drug loaded liposomes by mononuclear phagocytes infected with Leishmania donovani. Mol. Biochem. Parasitol. 12, 49-60. (Pubitemid 14056236)
-
(1984)
Molecular and Biochemical Parasitology
, vol.12
, Issue.1
, pp. 49-60
-
-
Heath, S.1
Chance, M.L.2
New, R.R.C.3
-
80
-
-
0033517487
-
Leishmaniasis
-
DOI 10.1016/S0140-6736(98)10178-2
-
Herwaldt, B.L., 1999. Leishmaniasis. Lancet 354, 1191-1199. (Pubitemid 29460458)
-
(1999)
Lancet
, vol.354
, Issue.9185
, pp. 1191-1199
-
-
Herwaldt, B.L.1
-
81
-
-
0026729038
-
Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies
-
Herwaldt, B.L., Berman, J.D., 1992. Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies. Am. J. Trop. Med. Hyg. 46, 296-306.
-
(1992)
Am. J. Trop. Med. Hyg.
, vol.46
, pp. 296-306
-
-
Herwaldt, B.L.1
Berman, J.D.2
-
82
-
-
0036297426
-
A novel phase inversion-based process for the preparation of lipid nanocarriers
-
DOI 10.1023/A:1016121319668
-
Heurtault, B., Saulnier, P., Pech, B., Proust, J.E., Benoit, J.P., 2002. A novel phase inversion-based process for the preparation of lipid nanocarriers. Pharm. Res. 19, 875-880. (Pubitemid 34692585)
-
(2002)
Pharmaceutical Research
, vol.19
, Issue.6
, pp. 875-880
-
-
Heurtault, B.1
Saulnier, P.2
Pech, B.3
Proust, J.-E.4
Benoit, J.-P.5
-
83
-
-
68949214375
-
Lipid nanocapsules: A new platform for nanomedicine
-
Huynh, N.T., Passirani, C., Saulnier, P., Benoit, J.P., 2009. Lipid nanocapsules: a new platform for nanomedicine. Int. J. Pharm. 379, 201-209.
-
(2009)
Int. J. Pharm.
, vol.379
, pp. 201-209
-
-
Huynh, N.T.1
Passirani, C.2
Saulnier, P.3
Benoit, J.P.4
-
84
-
-
84865283547
-
Efficacy and toxicity of a tropically stable lipid-based formulation of amphotericin B (iCo-010) in a rat model of invasive candidiasis
-
Ibrahim, F., Gershkovich, P., Sivak, O., Wasan, E.K., Bartlett, K., Wasan, K.M., 2012a. Efficacy and toxicity of a tropically stable lipid-based formulation of amphotericin B (iCo-010) in a rat model of invasive candidiasis. Int. J. Pharm. 436, 318-323.
-
(2012)
Int. J. Pharm.
, vol.436
, pp. 318-323
-
-
Ibrahim, F.1
Gershkovich, P.2
Sivak, O.3
Wasan, E.K.4
Bartlett, K.5
Wasan, K.M.6
-
85
-
-
84861194541
-
Assessment of novel oral lipid-based formulations of amphotericin B using an in vitro lipolysis model
-
Ibrahim, F., Gershkovich, P., Sivak, O., Wasan, E.K., Wasan, K.M., 2012b. Assessment of novel oral lipid-based formulations of amphotericin B using an in vitro lipolysis model. Eur. J. Pharm. Sci. 46, 323-328.
-
(2012)
Eur. J. Pharm. Sci.
, vol.46
, pp. 323-328
-
-
Ibrahim, F.1
Gershkovich, P.2
Sivak, O.3
Wasan, E.K.4
Wasan, K.M.5
-
86
-
-
0031783879
-
Chitosan and its use as a pharmaceutical excipient
-
DOI 10.1023/A:1011929016601
-
Illum, L., 1998. Chitosan and its use as a pharmaceutical excipient. Pharm. Res. 15, 1326-1331. (Pubitemid 28427917)
-
(1998)
Pharmaceutical Research
, vol.15
, Issue.9
, pp. 1326-1331
-
-
Illum, L.1
-
87
-
-
84865136915
-
Evaluating the potential of polyester nanoparticles for per oral delivery of amphotericin B in treating visceral leishmaniasis
-
Italia, J.L., Kumar, M.N., Carter, K.C., 2012. Evaluating the potential of polyester nanoparticles for per oral delivery of amphotericin B in treating visceral leishmaniasis. J. Biomed. Nanotechnol. 8, 695-702.
-
(2012)
J. Biomed. Nanotechnol.
, vol.8
, pp. 695-702
-
-
Italia, J.L.1
Kumar, M.N.2
Carter, K.C.3
-
88
-
-
80053613500
-
Peroral amphotericin B polymer nanoparticles lead to comparable or superior in vivo antifungal activity to that of intravenous Ambisome® or Fungizone™
-
Italia, J.L., Sharp, A., Carter, K.C., Warn, P., Kumar, M.N.V.R., 2011. Peroral amphotericin B polymer nanoparticles lead to comparable or superior in vivo antifungal activity to that of intravenous Ambisome® or Fungizone™. PLoS ONE 6, e25744.
-
(2011)
PLoS ONE
, vol.6
-
-
Italia, J.L.1
Sharp, A.2
Carter, K.C.3
Warn, P.4
Kumar, M.N.V.R.5
-
89
-
-
67349276996
-
Biodegradable nanoparticles improve oral bioavailability of amphotericin B and show reduced nephrotoxicity compared to intravenous fungizone
-
Italia, J.L., Yahya, M.M., Singh, D., Ravi Kumar, M.N., 2009. Biodegradable nanoparticles improve oral bioavailability of amphotericin B and show reduced nephrotoxicity compared to intravenous fungizone. Pharm. Res. 26, 1324-1331.
-
(2009)
Pharm. Res.
, vol.26
, pp. 1324-1331
-
-
Italia, J.L.1
Yahya, M.M.2
Singh, D.3
Ravi Kumar, M.N.4
-
90
-
-
84865966794
-
Gelatin coated hybrid lipid nanoparticles for oral delivery of amphotericin B
-
Jain, S., Valvi, P.U., Swarnakar, N.K., Thanki, K., 2012. Gelatin coated hybrid lipid nanoparticles for oral delivery of amphotericin B. Mol. Pharm. 9, 2542-2553.
-
(2012)
Mol. Pharm.
, vol.9
, pp. 2542-2553
-
-
Jain, S.1
Valvi, P.U.2
Swarnakar, N.K.3
Thanki, K.4
-
91
-
-
0001571784
-
Unusual lipid structures selectively reduce the toxicity of amphotericin B
-
Janoff, A.S., Boni, L.T., Popescu, M.C., Minchey, S.R., Cullis, P.R., Madden, T.D., Taraschi, T., Gruner, S.M., Shyamsunder, E., Tate, M.W., et al., 1988. Unusual lipid structures selectively reduce the toxicity of amphotericin B. Proc. Natl. Acad. Sci. U.S.A. 85, 6122-6126.
-
(1988)
Proc. Natl. Acad. Sci. U.S.A.
, vol.85
, pp. 6122-6126
-
-
Janoff, A.S.1
Boni, L.T.2
Popescu, M.C.3
Minchey, S.R.4
Cullis, P.R.5
Madden, T.D.6
Taraschi, T.7
Gruner, S.M.8
Shyamsunder, E.9
Tate, M.W.10
-
92
-
-
0033540005
-
Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis
-
Jha, T.K., Sundar, S., Thakur, C.P., Bachmann, P., Karbwang, J., Fischer, C., Voss, A., Berman, J., 1999. Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis. N. Engl. J. Med. 341, 1795-1800.
-
(1999)
N. Engl. J. Med.
, vol.341
, pp. 1795-1800
-
-
Jha, T.K.1
Sundar, S.2
Thakur, C.P.3
Bachmann, P.4
Karbwang, J.5
Fischer, C.6
Voss, A.7
Berman, J.8
-
93
-
-
29844441606
-
A phase II dose-ranging study of sitamaquine for the treatment of visceral leishmaniasis in India
-
Jha, T.K., Sundar, S., Thakur, C.P., Felton, J.M., Sabin, A.J., Horton, J., 2005. A phase II dose-ranging study of sitamaquine for the treatment of visceral leishmaniasis in India. Am. J. Trop. Med. Hyg. 73, 1005-1011. (Pubitemid 43038244)
-
(2005)
American Journal of Tropical Medicine and Hygiene
, vol.73
, Issue.6
, pp. 1005-1011
-
-
Jha, T.K.1
Sundar, S.2
Thakur, C.P.3
Felton, J.M.4
Sabin, A.J.5
Horton, J.6
-
94
-
-
59649112802
-
Paromomycin: Uptake and resistance in Leishmania donovani
-
Jhingran, A., Chawla, B., Saxena, S., Barrett, M.P., Madhubala, R., 2009. Paromomycin: uptake and resistance in Leishmania donovani. Mol. Biochem. Parasitol. 164, 111-117.
-
(2009)
Mol. Biochem. Parasitol.
, vol.164
, pp. 111-117
-
-
Jhingran, A.1
Chawla, B.2
Saxena, S.3
Barrett, M.P.4
Madhubala, R.5
-
95
-
-
34247478820
-
-
U.S.A.
-
Jin, T., Zarif, L., Mannino, R.J., 2000. Nano-cochleate formulations, process of preparation and method of delivery of pharmaceutical agents, U.S.A.
-
(2000)
Nano-cochleate Formulations, Process of Preparation and Method of Delivery of Pharmaceutical Agents
-
-
Jin, T.1
Zarif, L.2
Mannino, R.J.3
-
96
-
-
0026514067
-
Inhibiting cholesterol synthesis reduces the binding and toxicity of amphotericin B against rabbit renal tubular cells in primary culture
-
Joly, V., Saint-Pierre-Chazalet, M., Saint-Julien, L., Bolard, J., Carbon, C., Yeni, P., 1992. Inhibiting cholesterol synthesis reduces the binding and toxicity of amphotericin B against rabbit renal tubular cells in primary culture. J. Infect. Dis. 165, 337-343.
-
(1992)
J. Infect. Dis.
, vol.165
, pp. 337-343
-
-
Joly, V.1
Saint-Pierre-Chazalet, M.2
Saint-Julien, L.3
Bolard, J.4
Carbon, C.5
Yeni, P.6
-
97
-
-
80054697161
-
Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: Basic approaches and practical applications
-
Kawabata, Y., Wada, K., Nakatani, M., Yamada, S., Onoue, S., 2011. Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications. Int. J. Pharm. 420, 1-10.
-
(2011)
Int. J. Pharm.
, vol.420
, pp. 1-10
-
-
Kawabata, Y.1
Wada, K.2
Nakatani, M.3
Yamada, S.4
Onoue, S.5
-
98
-
-
0033970268
-
Nanosuspensions for the formulation of aphidicolin to improve drug targeting effects against Leishmania infected macrophages
-
DOI 10.1016/S0378-5173(99)00434-2, PII S0378517399004342
-
Kayser, O., 2000. Nanosuspensions for the formulation of aphidicolin to improve drug targeting effects against leishmania infected macrophages. Int. J. Pharm. 196, 253-256. (Pubitemid 30105755)
-
(2000)
International Journal of Pharmaceutics
, vol.196
, Issue.2
, pp. 253-256
-
-
Kayser, O.1
-
99
-
-
0037453179
-
Formulation of amphotericin B as nanosuspension for oral administration
-
DOI 10.1016/S0378-5173(02)00686-5
-
Kayser, O., Olbrich, C., Yardley, V., Kiderlen, A.F., Croft, S.L., 2003. Formulation of amphotericin B as nanosuspension for oral administration. Int. J. Pharm. 254, 73-75. (Pubitemid 36259814)
-
(2003)
International Journal of Pharmaceutics
, vol.254
, Issue.1
, pp. 73-75
-
-
Kayser, O.1
Olbrich, C.2
Yardley, V.3
Kiderlen, A.F.4
Croft, S.L.5
-
100
-
-
33846847777
-
Leishmania vaccines: Progress and problems
-
DOI 10.1017/S0031182006001831, PII S0031182006001831
-
Kedzierski, L., Zhu, Y., Handman, E., 2006. Leishmania vaccines: progress and problems. Parasitology 133 (Suppl.), S87-S112. (Pubitemid 46208033)
-
(2006)
Parasitology
, vol.133
, Issue.SUPPL.2
-
-
Kedzierski, L.1
Zhu, Y.2
Handman, E.3
-
101
-
-
34548049483
-
Nanosizing - Oral formulation development and biopharmaceutical evaluation
-
DOI 10.1016/j.addr.2007.05.003, PII S0169409X0700083X
-
Kesisoglou, F., Panmai, S., Wu, Y., 2007. Nanosizing-oral formulation development and biopharmaceutical evaluation. Adv. Drug Deliv. Rev. 59, 631-644. (Pubitemid 47285408)
-
(2007)
Advanced Drug Delivery Reviews
, vol.59
, Issue.7
, pp. 631-644
-
-
Kesisoglou, F.1
Panmai, S.2
Wu, Y.3
-
102
-
-
0043212012
-
Polymeric microspheres for drug delivery to the oral cavity: An in vitro evaluation of mucoadhesive potential
-
DOI 10.1002/jps.10423
-
Kockisch, S., Rees, G.D., Young, S.A., Tsibouklis, J., Smart, J.D., 2003. Polymeric microspheres for drug delivery to the oral cavity: an in vitro evaluation of mucoadhesive potential. J. Pharm. Sci. 92, 1614-1623. (Pubitemid 36929681)
-
(2003)
Journal of Pharmaceutical Sciences
, vol.92
, Issue.8
, pp. 1614-1623
-
-
Kockisch, S.1
Rees, G.D.2
Young, S.A.3
Tsibouklis, J.4
Smart, J.D.5
-
103
-
-
84859947948
-
Exploring oral nanoemulsions for bioavailability enhancement of poorly water-soluble drugs
-
Kotta, S., Khan, A.W., Pramod, K., Ansari, S.H., Sharma, R.K., Ali, J., 2012. Exploring oral nanoemulsions for bioavailability enhancement of poorly water-soluble drugs. Expert Opin. Drug Deliv. 9, 585-598.
-
(2012)
Expert Opin. Drug Deliv.
, vol.9
, pp. 585-598
-
-
Kotta, S.1
Khan, A.W.2
Pramod, K.3
Ansari, S.H.4
Sharma, R.K.5
Ali, J.6
-
104
-
-
0035958829
-
A randomised, blinded, placebo-controlled clinical trial with allopurinol in canine leishmaniosis
-
DOI 10.1016/S0304-4017(01)00399-5, PII S0304401701003995
-
Koutinas, A.F., Saridomichelakis, M.N., Mylonakis, M.E., Leontides, L., Polizopoulou, Z., Billinis, C., Argyriadis, D., Diakou, N., Papadopoulos, O., 2001. A randomised, blinded, placebo-controlled clinical trial with allopurinol in canine leishmaniosis. Vet. Parasitol. 98, 247-261. (Pubitemid 32553825)
-
(2001)
Veterinary Parasitology
, vol.98
, Issue.4
, pp. 247-261
-
-
Koutinas, A.F.1
Saridomichelakis, M.N.2
Mylonakis, M.E.3
Leontides, L.4
Polizopoulou, Z.5
Billinis, C.6
Argyriadis, D.7
Diakou, N.8
Papadopoulos, O.9
-
105
-
-
0025774705
-
Liposomes and nanoparticles as vehicles for antibiotics
-
Kreuter, J., 1991. Liposomes and nanoparticles as vehicles for antibiotics. Infection 19, S224-S228.
-
(1991)
Infection
, vol.19
-
-
Kreuter, J.1
-
106
-
-
84884150239
-
-
American Society for Microbiology, Washington, DC, ETATS-UNIS
-
Kuhlencord, A., Maniera, T., Eibl, H., Unger, C., 1992. Hexadecylphosphocholine: Oral Treatment of Visceral Leishmaniasis in Mice. American Society for Microbiology, Washington, DC, ETATS-UNIS.
-
(1992)
Hexadecylphosphocholine: Oral Treatment of Visceral Leishmaniasis in Mice
-
-
Kuhlencord, A.1
Maniera, T.2
Eibl, H.3
Unger, C.4
-
107
-
-
11144297274
-
Chitosan chemistry and pharmaceutical perspectives
-
DOI 10.1021/cr030441b
-
Kumar, M.N., Muzzarelli, R.A., Muzzarelli, C., Sashiwa, H., Domb, A.J., 2004. Chitosan chemistry and pharmaceutical perspectives. Chem. Rev. 104, 6017-6084. (Pubitemid 40025733)
-
(2004)
Chemical Reviews
, vol.104
, Issue.12
, pp. 6017-6084
-
-
Kumar, M.N.V.R.1
Muzzarelli, R.A.A.2
Muzzarelli, C.3
Sashiwa, H.4
Domb, A.J.5
-
109
-
-
3042844195
-
Harmine: Evaluation of its antileishmanial properties in various vesicular delivery systems
-
Lala, S., Pramanick, S., Mukhopadhyay, S., Bandyopadhyay, S., Basu, M.K., 2004. Harmine: evaluation of its antileishmanial properties in various vesicular delivery systems. J. Drug Target. 12, 165-175.
-
(2004)
J. Drug Target.
, vol.12
, pp. 165-175
-
-
Lala, S.1
Pramanick, S.2
Mukhopadhyay, S.3
Bandyopadhyay, S.4
Basu, M.K.5
-
110
-
-
0033840158
-
Polyisobutylcyanoacrylate nanocapsules containing an aqueous core as a novel colloidal carrier for the delivery of oligonucleotides
-
DOI 10.1023/A:1007582332491
-
Lambert, G., Fattal, E., Pinto-Alphandary, H., Gulik, A., Couvreur, P., 2000. Polyisobutylcyanoacrylate nanocapsules containing an aqueous core as a novel colloidal carrier for the delivery of oligonucleotides. Pharm. Res. 17, 707-714. (Pubitemid 30670637)
-
(2000)
Pharmaceutical Research
, vol.17
, Issue.6
, pp. 707-714
-
-
Lambert, G.1
Fattal, E.2
Pinto-Alphandary, H.3
Gulik, A.4
Couvreur, P.5
-
111
-
-
0017317645
-
Polymers for the sustained release of proteins and other macromolecules
-
Langer, R., Folkman, J., 1976. Polymers for the sustained release of proteins and other macromolecules. Nature 263, 797-800.
-
(1976)
Nature
, vol.263
, pp. 797-800
-
-
Langer, R.1
Folkman, J.2
-
112
-
-
77957799578
-
Cyclodextrins for drug delivery
-
Laza-Knoerr, A.L., Gref, R., Couvreur, P., 2010. Cyclodextrins for drug delivery. J. Drug Target. 18, 645-656.
-
(2010)
J. Drug Target.
, vol.18
, pp. 645-656
-
-
Laza-Knoerr, A.L.1
Gref, R.2
Couvreur, P.3
-
113
-
-
23444452243
-
Amphotericin B
-
DOI 10.1007/s00253-005-1955-9
-
Lemke, A., Kiderlen, A.F., Kayser, O., 2005. Amphotericin B. Appl. Microbiol. Biotechnol. 68, 151-162. (Pubitemid 41110936)
-
(2005)
Applied Microbiology and Biotechnology
, vol.68
, Issue.2
, pp. 151-162
-
-
Lemke, A.1
Kiderlen, A.F.2
Kayser, O.3
-
114
-
-
80051780560
-
In vitro cytotoxicity of two novel oral formulations of amphotericin B (iCo-009 and iCo-010) against Candida albicans, human monocytic and kidney cell lines
-
Leon, C.G., Lee, J., Bartlett, K., Gershkovich, P., Wasan, E.K., Zhao, J., Clement, J.G., Wasan, K.M., 2011. In vitro cytotoxicity of two novel oral formulations of amphotericin B (iCo-009 and iCo-010) against Candida albicans, human monocytic and kidney cell lines. Lipids Health Dis. 10, 144.
-
(2011)
Lipids Health Dis.
, vol.10
, pp. 144
-
-
Leon, C.G.1
Lee, J.2
Bartlett, K.3
Gershkovich, P.4
Wasan, E.K.5
Zhao, J.6
Clement, J.G.7
Wasan, K.M.8
-
115
-
-
0033509735
-
Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani
-
Lira, R., Sundar, S., Makharia, A., Kenney, R., Gam, A., Saraiva, E., Sacks, D., 1999. Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani. J. Infect. Dis. 180, 564-567.
-
(1999)
J. Infect. Dis.
, vol.180
, pp. 564-567
-
-
Lira, R.1
Sundar, S.2
Makharia, A.3
Kenney, R.4
Gam, A.5
Saraiva, E.6
Sacks, D.7
-
116
-
-
12644252548
-
Coccidioidomycosis and its treatment with amphotericin B
-
Littman, M.L., Horowitz, P.L., Swadey, J.G., 1958. Coccidioidomycosis and its treatment with amphotericin B. Am. J. Med. 24, 568-592.
-
(1958)
Am. J. Med.
, vol.24
, pp. 568-592
-
-
Littman, M.L.1
Horowitz, P.L.2
Swadey, J.G.3
-
117
-
-
23644462081
-
Cyclodextrins in drug delivery
-
DOI 10.1517/17425247.2.1.335
-
Loftsson, T., Jarho, P., Masson, M., Jarvinen, T., 2005. Cyclodextrins in drug delivery. Expert Opin. Drug Deliv. 2, 335-351. (Pubitemid 41130887)
-
(2005)
Expert Opinion on Drug Delivery
, vol.2
, Issue.2
, pp. 335-351
-
-
Loftsson, T.1
Jarho, P.2
Masson, M.3
Jarvinen, T.4
-
118
-
-
84856287868
-
Lipid nanoparticles containing oryzalin for the treatment of leishmaniasis
-
Lopes, R., Eleutério, C.V., Gonçalves, L.M.D., Cruz, M.E.M., Almeida, A.J., 2012. Lipid nanoparticles containing oryzalin for the treatment of leishmaniasis. Eur. J. Pharm. Sci. 45, 442-450.
-
(2012)
Eur. J. Pharm. Sci.
, vol.45
, pp. 442-450
-
-
Lopes, R.1
Eleutério, C.V.2
Gonçalves, L.M.D.3
Cruz, M.E.M.4
Almeida, A.J.5
-
119
-
-
0001417138
-
Some aspects of the absorption, distribution, and excretion of amphotericin B in man
-
Louria, D.B., 1958. Some aspects of the absorption, distribution, and excretion of amphotericin B in man. Antib. Med. Clin. Ther. 5, 295-301.
-
(1958)
Antib. Med. Clin. Ther.
, vol.5
, pp. 295-301
-
-
Louria, D.B.1
-
120
-
-
85028127551
-
Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs
-
Lu, Y., Park, K., 2012. Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs. Int. J. Pharm., http://dx.doi.org/ 10.1016/j.ijpharm.2012.08.042.
-
(2012)
Int. J. Pharm.
-
-
Lu, Y.1
Park, K.2
-
121
-
-
0037446277
-
Enhanced loading of water-soluble actives into bicontinuous cubic phase liquid crystals using cationic surfactants
-
DOI 10.1016/S0021-9797(02)00016-4
-
Lynch, M.L., Ofori-Boateng, A., Hippe, A., Kochvar, K., Spicer, P.T., 2003. Enhanced loading of water-soluble actives into bicontinuous cubic phase liquid crystals using cationic surfactants. J. Colloids Interface Sci. 260, 404-413. (Pubitemid 36401600)
-
(2003)
Journal of Colloid and Interface Science
, vol.260
, Issue.2
, pp. 404-413
-
-
Lynch, M.L.1
Ofori-Boateng, A.2
Hippe, A.3
Kochvar, K.4
Spicer, P.T.5
-
122
-
-
0032490554
-
Targeting immune response induction with cochleate and liposome-based vaccines
-
DOI 10.1016/S0169-409X(98)00014-3, PII S0169409X98000143
-
Mannino, R.J., Canki, M., Feketeova, E., Scolpino, A.J., Wang, Z., Zhang, F., Kheiri, M.T., Gould-Fogerite, S., 1998. Targeting immune response induction with cochleate and liposome-based vaccines. Adv. Drug Deliv. Rev. 32, 273-287. (Pubitemid 28267413)
-
(1998)
Advanced Drug Delivery Reviews
, vol.32
, Issue.3
, pp. 273-287
-
-
Gould-Fogerite, S.1
Kheiri, M.T.2
Zhang, F.3
Wang, Z.4
Scolpino, A.J.5
Feketeova, E.6
Canki, M.7
Mannino, R.J.8
-
123
-
-
0026076280
-
Purine analogs as chemotherapeutic agents in leishmaniasis and American trypanosomiasis
-
Marr, J.J., 1991. Purine analogs as chemotherapeutic agents in leishmaniasis and American trypanosomiasis. J. Lab. Clin. Med. 118, 111-119.
-
(1991)
J. Lab. Clin. Med.
, vol.118
, pp. 111-119
-
-
Marr, J.J.1
-
124
-
-
33750265012
-
Mode of action of beta-cyclodextrin as an absorption enhancer of the water-soluble drug meglumine antimoniate
-
DOI 10.1016/j.ijpharm.2006.06.014, PII S0378517306004832
-
Martins, P.S., Ochoa, R., Pimenta, A.M.C., Ferreira, L.A.M., Melo, A.L., da Silva, J.B.B., Sinisterra, R.D., Demicheli, C., Frézard, F., 2006. Mode of action of β-cyclodextrin as an absorption enhancer of the water-soluble drug meglumine antimoniate. Int. J. Pharm. 325, 39-47. (Pubitemid 44608216)
-
(2006)
International Journal of Pharmaceutics
, vol.325
, Issue.1-2
, pp. 39-47
-
-
Martins, P.S.1
Ochoa, R.2
Pimenta, A.M.C.3
Ferreira, L.A.M.4
Melo, A.L.5
Da, S.J.B.B.6
Sinisterra, R.D.7
Demicheli, C.8
Frezard, F.9
-
125
-
-
84905783840
-
Leishmaniasis: Clinical syndromes and treatment
-
McGwire, B.S., Satoskar, A.R., 2013. Leishmaniasis: clinical syndromes and treatment. QJM, http://dx.doi.org/10.1093/qjmed/hct116.
-
(2013)
QJM
-
-
McGwire, B.S.1
Satoskar, A.R.2
-
126
-
-
0035946615
-
Solid lipid nanoparticles: Production, characterization and applications
-
DOI 10.1016/S0169-409X(01)00105-3, PII S0169409X01001053
-
Mehnert, W., Mäder, K., 2001. Solid lipid nanoparticles: production, characterization and applications. Adv. Drug Deliv. Rev. 47, 165-196. (Pubitemid 32324113)
-
(2001)
Advanced Drug Delivery Reviews
, vol.47
, Issue.2-3
, pp. 165-196
-
-
Mehnert, W.1
Mader, K.2
-
127
-
-
34548707878
-
Treatment of kala-azar in southern Sudan using a 17-day regimen of sodium stibogluconate combined with paromomycin: A retrospective comparison with 30-day sodium stibogluconate monotherapy
-
Melaku, Y., Collin, S.M., Keus, K., Gatluak, F., Ritmeijer, K., Davidson, R.N., 2007. Treatment of kala-azar in southern Sudan using a 17-day regimen of sodium stibogluconate combined with paromomycin: a retrospective comparison with 30-day sodium stibogluconate monotherapy. Am. J. Trop. Med. Hyg. 77, 89-94.
-
(2007)
Am. J. Trop. Med. Hyg.
, vol.77
, pp. 89-94
-
-
Melaku, Y.1
Collin, S.M.2
Keus, K.3
Gatluak, F.4
Ritmeijer, K.5
Davidson, R.N.6
-
128
-
-
33750587653
-
Interaction between miltefosine and amphotericin B: Consequences for their activities towards intestinal epithelial cells and Leishmania donovani promastigotes in vitro
-
DOI 10.1128/AAC.00837-06
-
Ménez, C., Buyse, M., Besnard, M., Farinotti, R., Loiseau, P.M., Barratt, G., 2006a. Interaction between miltefosine and amphotericin B: consequences for their activities towards intestinal epithelial cells and Leishmania donovani promastigotes in vitro. Antimicrob. Agents Chemother. 50, 3793-3800. (Pubitemid 44684895)
-
(2006)
Antimicrobial Agents and Chemotherapy
, vol.50
, Issue.11
, pp. 3793-3800
-
-
Menez, C.1
Buyse, M.2
Besnard, M.3
Farinotti, R.4
Loiseau, P.M.5
Barratt, G.6
-
129
-
-
30444441660
-
Modulation of intestinal barrier properties by miltefosine
-
DOI 10.1016/j.bcp.2005.11.008, PII S0006295205007525
-
Ménez, C., Buyse, M., Chacun, H., Farinotti, R., Barratt, G., 2006b. Modulation of intestinal barrier properties by miltefosine. Biochem. Pharmacol. 71, 486-496. (Pubitemid 43077083)
-
(2006)
Biochemical Pharmacology
, vol.71
, Issue.4
, pp. 486-496
-
-
Menez, C.1
Buyse, M.2
Chacun, H.3
Farinotti, R.4
Barratt, G.5
-
130
-
-
34247367684
-
Physicochemical characterization of molecular assemblies of miltefosine and amphotericin B
-
DOI 10.1021/mp0601143
-
Ménez, C., Legrand, P., Rosilio, V., Lesieur, S., Barratt, G., 2007. Physicochemical characterization of molecular assemblies of miltefosine and amphotericin B. Mol. Pharm. 4, 281-288. (Pubitemid 46640604)
-
(2007)
Molecular Pharmaceutics
, vol.4
, Issue.2
, pp. 281-288
-
-
Menez, C.1
Legrand, P.2
Rosilio, V.3
Lesieur, S.4
Barratt, G.5
-
131
-
-
0025953652
-
Liposomal amphotericin B (AmBisome): Safety data from a phase II/III clinical trial
-
Meunier, F., Prentice, H.G., Ringdén, O., 1991. Liposomal amphotericin B (AmBisome): safety data from a phase II/III clinical trial. J. Antimicrob. Chemother. 28, 83-91.
-
(1991)
J. Antimicrob. Chemother.
, vol.28
, pp. 83-91
-
-
Meunier, F.1
Prentice, H.G.2
Ringdén, O.3
-
132
-
-
26944445100
-
Reorganization of lipid nanocapsules at air-water interface. Part 2. Properties of the formed surface film
-
DOI 10.1016/j.colsurfb.2005.07.001, PII S0927776505002080
-
Minkov, I., Ivanova, T., Panaiotov, I., Proust, J., Saulnier, P., 2005. Reorganization of lipid nanocapsules at air-water interface: part 2. Properties of the formed surface film. Colloids Surf. B: Biointerfaces 44, 197-203. (Pubitemid 44302094)
-
(2005)
Colloids and Surfaces B: Biointerfaces
, vol.44
, Issue.4
, pp. 197-203
-
-
Minkov, I.1
Ivanova, T..2
Panaiotov, I.3
Proust, J.4
Saulnier, P.5
-
133
-
-
84856287418
-
Current treatment of leishmaniasis: A review
-
Monzote, L., 2009. Current treatment of leishmaniasis: a review. Open Antimicrob. Agents J. 1, 9-19.
-
(2009)
Open Antimicrob. Agents J.
, vol.1
, pp. 9-19
-
-
Monzote, L.1
-
134
-
-
84884160665
-
Lipid-based formulations for oral administration of poorly water-soluble drugs
-
Mu, H., Holm, R., Müllertz, A., 2013. Lipid-based formulations for oral administration of poorly water-soluble drugs. Int. J. Pharm., http://dx.doi.org/10.1016/j.ijpharm.2013.03.054.
-
(2013)
Int. J. Pharm.
-
-
Mu, H.1
Holm, R.2
Müllertz, A.3
-
135
-
-
84867262237
-
Strategies for effective oral insulin delivery with modified chitosan nanoparticles: A review
-
Mukhopadhyay, P., Mishra, R., Rana, D., Kundu, P.P., 2012. Strategies for effective oral insulin delivery with modified chitosan nanoparticles: a review. Progr. Polym. Sci. 37, 1457-1475.
-
(2012)
Progr. Polym. Sci.
, vol.37
, pp. 1457-1475
-
-
Mukhopadhyay, P.1
Mishra, R.2
Rana, D.3
Kundu, P.P.4
-
136
-
-
0031658033
-
Visceral leishmaniasis in the BALB/c mouse: A comparison of the efficacy of a nonionic surfactant formulation of sodium stibogluconate with those of three proprietary formulations of amphotericin B
-
Mullen, A.B., Baillie, A.J., Carter, K.C., 1998. Visceral leishmaniasis in the BALB/c mouse: a comparison of the efficacy of a nonionic surfactant formulation of sodium stibogluconate with those of three proprietary formulations of amphotericin B. Antimicrob. Agents Chemother. 42, 2722-2725. (Pubitemid 28462922)
-
(1998)
Antimicrobial Agents and Chemotherapy
, vol.42
, Issue.10
, pp. 2722-2725
-
-
Mullen, A.B.1
Baillie, A.J.2
Carter, K.C.3
-
137
-
-
34547883880
-
Lipid nanoparticles: recent advances
-
DOI 10.1016/j.addr.2007.05.002, PII S0169409X07000750, Lipid Nanoparticles: Recent Advances
-
Müller, R.H., 2007. Lipid nanoparticles: recent advances. Adv. Drug Deliv. Rev. 59, 375-376. (Pubitemid 47260708)
-
(2007)
Advanced Drug Delivery Reviews
, vol.59
, Issue.6
, pp. 375-376
-
-
Muller, R.H.1
-
138
-
-
0035937599
-
Nanosuspensions as particulate drug formulations in therapy: Rationale for development and what we can expect for the future
-
DOI 10.1016/S0169-409X(00)00118-6, PII S0169409X00001186
-
Muller, R.H., Jacobs, C., Kayser, O., 2001. Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. Adv. Drug Deliv. Rev. 47, 3-19. (Pubitemid 32209229)
-
(2001)
Advanced Drug Delivery Reviews
, vol.47
, Issue.1
, pp. 3-19
-
-
Muller, R.H.1
Jacobs, C.2
Kayser, O.3
-
139
-
-
0038032150
-
Solid lipid nanoparticles (SLN) for controlled drug delivery - A review of the state of the art
-
DOI 10.1016/S0939-6411(00)00087-4, PII S0939641100000874
-
Muller, R.H., Mader, K., Gohla, S., 2000. Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur. J. Pharm. Biopharm. 50, 161-177. (Pubitemid 30326695)
-
(2000)
European Journal of Pharmaceutics and Biopharmaceutics
, vol.50
, Issue.1
, pp. 161-177
-
-
Muller, R.H.1
Mader, K.2
Gohla, S.3
-
140
-
-
0342897023
-
Nanosuspensions for the formulation of poorly soluble drugs. I. Preparation by a size-reduction technique
-
DOI 10.1016/S0378-5173(97)00311-6, PII S0378517397003116
-
Müller, R.H., Peters, K., 1998. Nanosuspensions for the formulation of poorly soluble drugs: I. Preparation by a size-reduction technique. Int. J. Pharm. 160, 229-237. (Pubitemid 28083096)
-
(1998)
International Journal of Pharmaceutics
, vol.160
, Issue.2
, pp. 229-237
-
-
Muller, R.H.1
Peters, K.2
-
141
-
-
27544475529
-
Advances in leishmaniasis
-
DOI 10.1016/S0140-6736(05)67629-5, PII S0140673605676295
-
Murray, H.W., Berman, J.D., Davies, C.R., Saravia, N.G., 2005. Advances in leishmaniasis. Lancet 366, 1561-1577. (Pubitemid 41540115)
-
(2005)
Lancet
, vol.366
, Issue.9496
, pp. 1561-1577
-
-
Murray, H.W.1
Berman, J.D.2
Davies, C.R.3
Saravia, N.G.4
-
142
-
-
42949160050
-
Natural products as leads to potential drugs: An old process or the new hope for drug discovery?
-
DOI 10.1021/jm0704090
-
Newman, D.J., 2008. Natural products as leads to potential drugs: an old process or the new hope for drug discovery. J. Med. Chem. 51, 2589-2599. (Pubitemid 351620778)
-
(2008)
Journal of Medicinal Chemistry
, vol.51
, Issue.9
, pp. 2589-2599
-
-
Newman, D.J.1
-
143
-
-
0042424608
-
Pharmacokinetics, toxicities, and efficacies of sodium stibogluconate formulations after intravenous administration in animals
-
DOI 10.1128/AAC.47.9.2781-2787.2003
-
Nieto, J., Alvar, J., Mullen, A.B., Carter, K.C., Rodriguez, C., San Andres, M.I., San Andres, M.D., Baillie, A.J., Gonzalez, F., 2003. Pharmacokinetics, toxicities, and efficacies of sodium stibogluconate formulations after intravenous administration in animals. Antimicrob. Agents Chemother. 47, 2781-2787. (Pubitemid 37040248)
-
(2003)
Antimicrobial Agents and Chemotherapy
, vol.47
, Issue.9
, pp. 2781-2787
-
-
Nieto, J.1
Alvar, J.2
Mullen, A.B.3
Carter, K.C.4
Rodriguez, C.5
San, A.M.I.6
San, A.M.D.7
Baillie, A.J.8
Gonzalez, F.9
-
144
-
-
0028579488
-
Is one year follow-up justified in kala-azar post-treatment?
-
Nyakundi, P.M., Wasunna, K.M., Rashid, J.R., Gachihi, G.S., Mbugua, J., Kirigi, G., Muttunga, J., 1994. Is one year follow-up justified in kala-azar post-treatment? East Afr. Med. J. 71, 453-459.
-
(1994)
East Afr. Med. J.
, vol.71
, pp. 453-459
-
-
Nyakundi, P.M.1
Wasunna, K.M.2
Rashid, J.R.3
Gachihi, G.S.4
Mbugua, J.5
Kirigi, G.6
Muttunga, J.7
-
145
-
-
0027249951
-
Practical progress and new drugs for changing patterns of Leishmaniasis
-
DOI 10.1016/0169-4758(93)90231-4
-
Olliaro, P.L., Bryceson, A.D., 1993. Practical progress and new drugs for changing patterns of leishmaniasis. Parasitol. Today 9, 323-328. (Pubitemid 23238274)
-
(1993)
Parasitology Today
, vol.9
, Issue.9
, pp. 323-328
-
-
Olliaro, P.L.1
Bryceson, A.D.M.2
-
146
-
-
0018198851
-
Calcium induced lipid phase transitions and membrane fusion
-
Papahadjopoulos, D., Portis, A., Pangborn, W., 1978a. Calcium-induced lipid phase transition and membrane fusion. Ann. N. Y. Acad. Sci. 308, 50-66. (Pubitemid 8372517)
-
(1978)
Annals of the New York Academy of Sciences
, vol.VOL. 308
, pp. 50-66
-
-
Papahadjopoulos, D.1
Portis, A.2
Pangborn, W.3
-
147
-
-
0018198851
-
Calcium induced lipid phase transitions and membrane fusion
-
Papahadjopoulos, D., Portis, A., Pangborn, W., 1978b. Calcium induced phase changes and fusion in natural in natural and model membranes. Ann. N. Y. Acad. Sci. 308, 50-66. (Pubitemid 8372517)
-
(1978)
Annals of the New York Academy of Sciences
, vol.VOL. 308
, pp. 50-66
-
-
Papahadjopoulos, D.1
Portis, A.2
Pangborn, W.3
-
148
-
-
0016820946
-
Cochleate lipid cylinders: Formation by fusion of unilamellar lipid vesicles
-
Papahadjopoulos, D., Vail, W.J., Jacobson, K., Poste, G., 1975. Cochleate lipid cylinders: formation by fusion of unilamellar lipid vesicles. Biochim. Biophys. Acta (BBA): Biomembr. 394, 483-491.
-
(1975)
Biochim. Biophys. Acta (BBA): Biomembr.
, vol.394
, pp. 483-491
-
-
Papahadjopoulos, D.1
Vail, W.J.2
Jacobson, K.3
Poste, G.4
-
149
-
-
1442349131
-
Miltefosine Induces Apoptosis-Like Death in Leishmania donovani Promastigotes
-
DOI 10.1128/AAC.48.3.852-859.2004
-
Paris, C., Loiseau, P.M., Bories, C., Breard, J., 2004. Miltefosine induces apoptosis-like death in Leishmania donovani promastigotes. Antimicrob. Agents Chemother. 48, 852-859. (Pubitemid 38280335)
-
(2004)
Antimicrobial Agents and Chemotherapy
, vol.48
, Issue.3
, pp. 852-859
-
-
Paris, C.1
Loiseau, P.M.2
Bories, C.3
Breard, J.4
-
150
-
-
84856003815
-
AmbiOnp: Solid lipid nanoparticles of amphotericin B for oral administration
-
Patel, P.A., Patravale, V.B., 2011. AmbiOnp: solid lipid nanoparticles of amphotericin B for oral administration. J. Biomed. Nanotechnol. 7, 632-639.
-
(2011)
J. Biomed. Nanotechnol.
, vol.7
, pp. 632-639
-
-
Patel, P.A.1
Patravale, V.B.2
-
151
-
-
0035884996
-
Sodium stibogluconate is a potent inhibitor of protein tyrosine phosphatases and augments cytokine responses in hemopoietic cell lines
-
Pathak, M.K., Yi, T., 2001. Sodium stibogluconate is a potent inhibitor of protein tyrosine phosphatases and augments cytokine responses in hemopoietic cell lines. J. Immunol. 167, 3391-3397. (Pubitemid 32852583)
-
(2001)
Journal of Immunology
, vol.167
, Issue.6
, pp. 3391-3397
-
-
Pathak, M.K.1
Yi, T.2
-
152
-
-
0031740361
-
Physicochemical characteristics of pentamidine-loaded polymethacrylate nanoparticles: Implication in the intracellular drug release in Leishmania major infected mice
-
Paul, M., Durand, R., Boulard, Y., Fusai, T., Fernandez, C., Rivollet, D., Deniau, M., Astier, A., 1998. Physicochemical characteristics of pentamidine-loaded polymethacrylate nanoparticles: implication in the intracellular drug release in Leishmania major infected mice. J. Drug Target. 5, 481-490. (Pubitemid 28499682)
-
(1998)
Journal of Drug Targeting
, vol.5
, Issue.6
, pp. 481-490
-
-
Paul, M.1
Durand, R.2
Boulard, Y.3
Fusai, T.4
Fernandez, C.5
Rivollet, D.6
Deniau, M.7
Astier, A.8
-
153
-
-
0030231079
-
Enzyme-catalysed polymer modification: Reaction of phenolic compounds with chitosan films
-
DOI 10.1016/0032-3861(96)00338-2
-
Payne, G.F., Chaubal, M.V., Barbari, T.A., 1996. Enzyme-catalysed polymer modification: reaction of phenolic compounds with chitosan films. Polymer 37, 4643-4648. (Pubitemid 126382285)
-
(1996)
Polymer
, vol.37
, Issue.20
, pp. 4643-4648
-
-
Payne, G.F.1
Chaubal, M.V.2
Barbari, T.A.3
-
154
-
-
78649907878
-
Design and in vitro evaluation of capsaicin transdermal controlled release cubic phase gels
-
Peng, X., Wen, X., Pan, X., Wang, R., Chen, B., Wu, C., 2010. Design and in vitro evaluation of capsaicin transdermal controlled release cubic phase gels. AAPS PharmSciTech 11, 1405-1410.
-
(2010)
AAPS PharmSciTech
, vol.11
, pp. 1405-1410
-
-
Peng, X.1
Wen, X.2
Pan, X.3
Wang, R.4
Chen, B.5
Wu, C.6
-
155
-
-
33745253122
-
Mechanisms of experimental resistance of Leishmania to miltefosine: Implications for clinical use
-
DOI 10.1016/j.drup.2006.04.001, PII S1368764606000215
-
Pérez-Victoria, F.J., Sánchez-Canete, M.a.P., Seifert, K., Croft, S.L., Sundar, S., Castanys, S., Gamarro, F., 2006. Mechanisms of experimental resistance of Leishmania to miltefosine: implications for clinical use. Drug Resist. Updat. 9, 26-39. (Pubitemid 43928805)
-
(2006)
Drug Resistance Updates
, vol.9
, Issue.1-2
, pp. 26-39
-
-
Perez-Victoria, F.J.1
Sanchez-Canete, M.P.2
Seifert, K.3
Croft, S.L.4
Sundar, S.5
Castanys, S.6
Gamarro, F.7
-
156
-
-
33745253122
-
Mechanisms of experimental resistance of Leishmania to miltefosine: Implications for clinical use
-
DOI 10.1016/j.drup.2006.04.001, PII S1368764606000215
-
Perez-Victoria, F.J., Sanchez-Canete, M.P., Seifert, K., Croft, S.L., Sundar, S., Castanys, S., Gamarro, F., 2006. Mechanisms of experimental resistance of leishmania to miltefosine: implications for clinical use. Drug Resist. Updat. 9, 26-39. (Pubitemid 43928805)
-
(2006)
Drug Resistance Updates
, vol.9
, Issue.1-2
, pp. 26-39
-
-
Perez-Victoria, F.J.1
Sanchez-Canete, M.P.2
Seifert, K.3
Croft, S.L.4
Sundar, S.5
Castanys, S.6
Gamarro, F.7
-
157
-
-
53049090855
-
Leishmaniasis: Drug resistance and natural products
-
review
-
Polonio, T., Efferth, T., 2008. Leishmaniasis: drug resistance and natural products (review). Int. J. Mol. Med. 22, 277-286.
-
(2008)
Int. J. Mol. Med.
, vol.22
, pp. 277-286
-
-
Polonio, T.1
Efferth, T.2
-
158
-
-
33847394968
-
Lipids and lipid-based formulations: Optimizing the oral delivery of lipophilic drugs
-
DOI 10.1038/nrd2197, PII NRD2197
-
Porter, C.J., Trevaskis, N.L., Charman, W.N., 2007. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat. Rev. Drug Discov. 6, 231-248. (Pubitemid 46344627)
-
(2007)
Nature Reviews Drug Discovery
, vol.6
, Issue.3
, pp. 231-248
-
-
Porter, C.J.H.1
Trevaskis, N.L.2
Charman, W.N.3
-
159
-
-
0035940057
-
Intestinal lymphatic drug transport: An update
-
DOI 10.1016/S0169-409X(01)00151-X, PII S0169409X0100151X
-
Porter, C.J.H., Charman, W.N., 2001. Intestinal lymphatic drug transport: an update. Adv. Drug Deliv. Rev. 50, 61-80. (Pubitemid 32727277)
-
(2001)
Advanced Drug Delivery Reviews
, vol.50
, Issue.1-2
, pp. 61-80
-
-
Porter, C.J.H.1
Charman, W.N.2
-
160
-
-
33751014029
-
Formulation of poorly water-soluble drugs for oral administration: Physicochemical and physiological issues and the lipid formulation classification system
-
DOI 10.1016/j.ejps.2006.04.016, PII S0928098706001151
-
Pouton, C.W., 2006. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur. J. Pharm. Sci. 29, 278-287. (Pubitemid 44740131)
-
(2006)
European Journal of Pharmaceutical Sciences
, vol.29
, Issue.3-4 SPEC. ISS.
, pp. 278-287
-
-
Pouton, C.W.1
-
161
-
-
1542314456
-
Miltefosine: An Oral Drug for Visceral Leishmaniasis
-
Prasad, R., Kumar, R., Jaiswal, B., Singh, U., 2004. Miltefosine: an oral drug for visceral leishmaniasis. Indian J. Pediatr. 71, 143-144. (Pubitemid 38325649)
-
(2004)
Indian Journal of Pediatrics
, vol.71
, Issue.2
, pp. 143-144
-
-
Prasad, R.1
Kumar, R.2
Jaiswal, B.P.3
Singh, U.K.4
-
162
-
-
84862944418
-
Mechanism of amphotericin B resistance in clinical isolates of Leishmania donovani
-
Purkait, B., Kumar, A., Nandi, N., Sardar, A.H., Das, S., Kumar, S., Pandey, K., Ravidas, V., Kumar, M., De, T., Singh, D., Das, P., 2012. Mechanism of amphotericin B resistance in clinical isolates of Leishmania donovani. Antimicrob. Agents Chemother. 56, 1031-1041.
-
(2012)
Antimicrob. Agents Chemother.
, vol.56
, pp. 1031-1041
-
-
Purkait, B.1
Kumar, A.2
Nandi, N.3
Sardar, A.H.4
Das, S.5
Kumar, S.6
Pandey, K.7
Ravidas, V.8
Kumar, M.9
De, T.10
Singh, D.11
Das, P.12
-
163
-
-
79959350104
-
Oral lipid based drug delivery system (LBDDS): Formulation, characterization and application: A review
-
Rahman, M.A., Harwansh, R., Mirza, M.A., Hussain, S., Hussain, A., 2011. Oral lipid based drug delivery system (LBDDS): formulation, characterization and application: a review. Curr. Drug Deliv. 8, 330-345.
-
(2011)
Curr. Drug Deliv.
, vol.8
, pp. 330-345
-
-
Rahman, M.A.1
Harwansh, R.2
Mirza, M.A.3
Hussain, S.4
Hussain, A.5
-
164
-
-
34347324117
-
Preparation of liquid-core nanocapsules from poly[(ethylene oxide-co-glycidol)] with multiple hydrophobic linoleates at an oil-water interface and its encapsulation of Pyrene
-
DOI 10.1021/bm0701797
-
Ren, Y., Wang, G., Huang, J., 2007. Preparation of liquid-core nanocapsules from poly[(ethylene oxide)-co-glycidol] with multiple hydrophobic linoleates at an oil-water interface and its encapsulation of pyrene. Biomacromolecules 8, 1873-1880. (Pubitemid 47009966)
-
(2007)
Biomacromolecules
, vol.8
, Issue.6
, pp. 1873-1880
-
-
Ren, Y.1
Wang, G.2
Huang, J.3
-
165
-
-
4544259600
-
Recent advances in vaccines for leishmaniasis
-
DOI 10.1517/14712598.4.9.1505
-
Requena, J.M., Iborra, S., Carrion, J., Alonso, C., Soto, M., 2004. Recent advances in vaccines for leishmaniasis. Expert Opin. Biol. Ther. 4, 1505-1517. (Pubitemid 39222982)
-
(2004)
Expert Opinion on Biological Therapy
, vol.4
, Issue.9
, pp. 1505-1517
-
-
Requena, J.M.1
Iborra, S.2
Carrion, J.3
Alonso, C.4
Soto, M.5
-
166
-
-
77951062455
-
Prolonged absorption of antimony(V) by the oral route from non-inclusion meglumine antimoniate-beta-cyclodextrin conjugates
-
Ribeiro, R.R., Ferreira, W.A., Martins, P.S., Neto, R.L., Rocha, O.G., Le Moyec, L., Demicheli, C., Frezard, F., 2010. Prolonged absorption of antimony(V) by the oral route from non-inclusion meglumine antimoniate-beta- cyclodextrin conjugates. Biopharm. Drug Dispos. 31, 109-119.
-
(2010)
Biopharm. Drug Dispos.
, vol.31
, pp. 109-119
-
-
Ribeiro, R.R.1
Ferreira, W.A.2
Martins, P.S.3
Neto, R.L.4
Rocha, O.G.5
Le Moyec, L.6
Demicheli, C.7
Frezard, F.8
-
167
-
-
0141890238
-
Effects of lipid-based oral formulations on plasma and tissue amphotericin B concentrations and renal toxicity in male rats
-
DOI 10.1128/AAC.47.10.3339-3342.2003
-
Risovic, V., Boyd, M., Choo, E., Wasan, K.M., 2003. Effects of lipid-based oral formulations on plasma and tissue amphotericin B concentrations and renal toxicity in male rats. Antimicrob. Agents Chemother. 47, 3339-3342. (Pubitemid 37229601)
-
(2003)
Antimicrobial Agents and Chemotherapy
, vol.47
, Issue.10
, pp. 3339-3342
-
-
Risovic, V.1
Boyd, M.2
Choo, E.3
Wasan, K.M.4
-
168
-
-
0032929618
-
Poor and unusually prolonged oral absorption of amphotericin B in rats
-
DOI 10.1023/A:1011961322883
-
Robbie, G., Wu, T.-C., Chiou, W., 1999. Poor and unusually prolonged oral absorption of amphotericin B in rats. Pharm. Res. 16, 455-458. (Pubitemid 29162106)
-
(1999)
Pharmaceutical Research
, vol.16
, Issue.3
, pp. 455-458
-
-
Robbie, G.1
Wu, T.-C.2
Chiou, W.L.3
-
170
-
-
78651495075
-
Studies on 6-chloro-5-(1-naphthyloxy)-2-(trifluoromethyl)-1H- benzimidazole/2-hydroxypropyl-b eta-cyclodextrin association: Characterization, molecular modeling studies, and in vivo anthelminthic activity
-
Rojas-Aguirre, Y., Yepez-Mulia, L., Castillo, I., Lopez-Vallejo, F., Soria-Arteche, O., Hernandez-Campos, A., Castillo, R., Hernandez-Luis, F., 2011. Studies on 6-chloro-5-(1-naphthyloxy)-2-(trifluoromethyl)-1H-benzimidazole/2- hydroxypropyl-b eta-cyclodextrin association: characterization, molecular modeling studies, and in vivo anthelminthic activity. Bioorg. Med. Chem. 19, 789-797.
-
(2011)
Bioorg. Med. Chem.
, vol.19
, pp. 789-797
-
-
Rojas-Aguirre, Y.1
Yepez-Mulia, L.2
Castillo, I.3
Lopez-Vallejo, F.4
Soria-Arteche, O.5
Hernandez-Campos, A.6
Castillo, R.7
Hernandez-Luis, F.8
-
171
-
-
0023696659
-
Amphotericin B-sterol complex formation and competition with egg phosphatidylcholine: A monolayer study
-
Saint-Pierre-Chazalet, M., Thomas, C., Dupeyrat, M., Gary-Bobo, C.M., 1988. Amphotericin B-sterol complex formation and competition with egg phosphatidylcholine: a monolayer study. Biochimica et Biophysica Acta (BBA) - Biomembranes 944, 477-486.
-
(1988)
Biochimica et Biophysica Acta (BBA) - Biomembranes
, vol.944
, pp. 477-486
-
-
Saint-Pierre-Chazalet, M.1
Thomas, C.2
Dupeyrat, M.3
Gary-Bobo, C.M.4
-
172
-
-
83455200692
-
Nanocochleate - A new approach in lipid drug delivery
-
Sankar, V., Reddy, Y., 2010. Nanocochleate - a new approach in lipid drug delivery. Int. J. Pharm. Pharm. Sci. 2, 220-223.
-
(2010)
Int. J. Pharm. Pharm. Sci.
, vol.2
, pp. 220-223
-
-
Sankar, V.1
Reddy, Y.2
-
173
-
-
19444375996
-
Enhancement of oral bioavailability of poorly water-soluble drugs by poly(ethylene glycol)-block-poly(alkyl acrylate-co-methacrylic acid) self-assemblies
-
DOI 10.1016/j.jconrel.2005.02.010, PII S0168365905000763
-
Sant, V.P., Smith, D., Leroux, J.-C., 2005. Enhancement of oral bioavailability of poorly water-soluble drugs by poly(ethylene glycol)-block-poly(alkyl acrylateco-methacrylic acid) self-assemblies. J. Control. Release 104, 289-300. (Pubitemid 40724930)
-
(2005)
Journal of Controlled Release
, vol.104
, Issue.2
, pp. 289-300
-
-
Sant, V.P.1
Smith, D.2
Leroux, J.-C.3
-
174
-
-
0033844882
-
Efficacy of oral cochleate-amphotericin B in a mouse model of systemic candidiasis
-
Santangelo, R., Paderu, P., Delmas, G., Chen, Z.W., Mannino, R., Zarif, L., Perlin, D.S., 2000.Efficacy of oral cochleate-amphotericin B in a mouse model of systemic candidiasis. Antimicrob. Agents Chemother. 44, 2356-2360.
-
(2000)
Antimicrob. Agents Chemother.
, vol.44
, pp. 2356-2360
-
-
Santangelo, R.1
Paderu, P.2
Delmas, G.3
Chen, Z.W.4
Mannino, R.5
Zarif, L.6
Perlin, D.S.7
-
175
-
-
0034605692
-
Colloidal carriers for benzathine penicillin G: Nanoemulsions and nanocapsules
-
Santos-Magalhaes, N.S., Pontes, A., Pereira, V.M., Caetano, M.N., 2000. Colloidal carriers for benzathine penicillin G: nanoemulsions and nanocapsules. Int. J. Pharm. 208, 71-80.
-
(2000)
Int. J. Pharm.
, vol.208
, pp. 71-80
-
-
Santos-Magalhaes, N.S.1
Pontes, A.2
Pereira, V.M.3
Caetano, M.N.4
-
176
-
-
0036968461
-
Quercetin: Critical evaluation as an antileishmanial agent in vivo in hamsters using different vesicular delivery modes
-
Sarkar, S., Mandal, S., Sinha, J., Mukhopadhyay, S., Das, N., Basu, M.K., 2002. Quercetin: critical evaluation as an antileishmanial agent in vivo in hamsters using different vesicular delivery modes. J. Drug Target. 10, 573-578.
-
(2002)
J. Drug Target.
, vol.10
, pp. 573-578
-
-
Sarkar, S.1
Mandal, S.2
Sinha, J.3
Mukhopadhyay, S.4
Das, N.5
Basu, M.K.6
-
177
-
-
35848959714
-
Alginate/chitosan nanoparticles are effective for oral insulin delivery
-
DOI 10.1007/s11095-007-9367-4
-
Sarmento, B., Ribeiro, A., Veiga, F., Sampaio, P., Neufeld, R., Ferreira, D., 2007. Alginate/chitosan nanoparticles are effective for oral insulin delivery. Pharm. Res. 24, 2198-2206. (Pubitemid 350060707)
-
(2007)
Pharmaceutical Research
, vol.24
, Issue.12
, pp. 2198-2206
-
-
Sarmento, B.1
Ribeiro, A.2
Veiga, F.3
Sampaio, P.4
Neufeld, R.5
Ferreira, D.6
-
178
-
-
33847337418
-
pH-responsive polymeric micelles of poly(ethylene glycol)-b- poly(alkyl(meth)acrylate-co-methacrylic acid): Influence of the copolymer composition on self-assembling properties and release of candesartan cilexetil
-
Satturwar, P., Eddine, M.N., Ravenelle, F., Leroux, J.C., 2007. pH-responsive polymeric micelles of poly(ethylene glycol)-b-poly(alkyl(meth) acrylate-co-methacrylic acid): influence of the copolymer composition on self-assembling properties and release of candesartan cilexetil. Eur. J. Pharm. Biopharm. 65, 379-387.
-
(2007)
Eur. J. Pharm. Biopharm.
, vol.65
, pp. 379-387
-
-
Satturwar, P.1
Eddine, M.N.2
Ravenelle, F.3
Leroux, J.C.4
-
179
-
-
0345643513
-
Chitosans as absorption enhancers of poorly absorbable drugs: 3: Influence of mucus on absorption enhancement
-
Schipper, N.G.M., Vårum, K.M., Stenberg, P., Ocklind, G., Lennernäs, H., Artursson, P., 1999. Chitosans as absorption enhancers of poorly absorbable drugs: 3: influence of mucus on absorption enhancement. Eur. J. Pharm. Sci. 8, 335-343.
-
(1999)
Eur. J. Pharm. Sci.
, vol.8
, pp. 335-343
-
-
Schipper, N.G.M.1
Vårum, K.M.2
Stenberg, P.3
Ocklind, G.4
Lennernäs, H.5
Artursson, P.6
-
180
-
-
0027097040
-
Aminosidine (paromomycin) in the treatment of leishmaniasis imported into the United Kingdom
-
DOI 10.1016/0035-9203(92)90151-2
-
Scott, J.A., Davidson, R.N., Moody, A.H., Grant, H.R., Felmingham, D., Scott, G.M., Olliaro, P., Bryceson, A.D., 1992. Aminosidine (paromomycin) in the treatment of leishmaniasis imported into the United Kingdom. Trans. R. Soc. Trop. Med. Hyg. 86, 617-619. (Pubitemid 23012904)
-
(1992)
Transactions of the Royal Society of Tropical Medicine and Hygiene
, vol.86
, Issue.6
, pp. 617-619
-
-
Scott, J.A.G.1
Davidson, R.N.2
Moody, A.H.3
Grant, H.R.4
Felmingham, D.5
Scott, G.M.S.6
Olliaro, P.7
Bryceson, A.D.M.8
-
181
-
-
0141457689
-
Characterisation of Leishmania donovani promastigotes resistant to hexadecylphosphocholine (miltefosine)
-
Seifert, K., Matu, S., Javier Pérez-Victoria, F., Castanys, S., Gamarro, F., Croft, S.L., 2003. Characterisation of Leishmania donovani promastigotes resistant to hexadecylphosphocholine (miltefosine). Int. J. Antimicrob. Agents 22, 380-387.
-
(2003)
Int. J. Antimicrob. Agents
, vol.22
, pp. 380-387
-
-
Seifert, K.1
Matu, S.2
Javier Pérez-Victoria, F.3
Castanys, S.4
Gamarro, F.5
Croft, S.L.6
-
182
-
-
34547337720
-
Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of Leishmania donovani and persists in vivo
-
DOI 10.1016/j.ijantimicag.2007.05.007, PII S092485790700252X
-
Seifert, K., Perez-Victoria, F.J., Stettler, M., Sanchez-Canete, M.P., Castanys, S., Gamarro, F., Croft, S.L., 2007. Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of Leishmania donovani and persists in vivo. Int. J. Antimicrob. Agents 30, 229-235. (Pubitemid 47135625)
-
(2007)
International Journal of Antimicrobial Agents
, vol.30
, Issue.3
, pp. 229-235
-
-
Seifert, K.1
Perez-Victoria, F.J.2
Stettler, M.3
Sanchez-Canete, M.P.4
Castanys, S.5
Gamarro, F.6
Croft, S.L.7
-
183
-
-
79955402141
-
In vitro activity of amphotericin B cochleates against Leishmania chagasi
-
Sesana, A.M., Monti-Rocha, R., Vinhas, S.A., Morais, C.G., Dietze, R., Lemos, E.M., 2011. In vitro activity of amphotericin B cochleates against Leishmania chagasi. Memórias do Instituto Oswaldo Cruz 106, 251-253.
-
(2011)
Memórias Do Instituto Oswaldo Cruz
, vol.106
, pp. 251-253
-
-
Sesana, A.M.1
Monti-Rocha, R.2
Vinhas, S.A.3
Morais, C.G.4
Dietze, R.5
Lemos, E.M.6
-
184
-
-
0035946622
-
Cubic phase gels as drug delivery systems
-
DOI 10.1016/S0169-409X(01)00108-9, PII S0169409X01001089
-
Shah, J.C., Sadhale, Y., Chilukuri, D.M., 2001. Cubic phase gels as drug delivery systems. Adv. Drug Deliv. Rev. 47, 229-250. (Pubitemid 32324116)
-
(2001)
Advanced Drug Delivery Reviews
, vol.47
, Issue.2-3
, pp. 229-250
-
-
Shah, J.C.1
Sadhale, Y.2
Chilukuri, D.M.3
-
185
-
-
84884145811
-
Development of oil-in-water microemulsions for the oral delivery of amphotericin B
-
Silva, A.E., Barratt, G., Chéron, M., Egito, E.S.T., 2013. Development of oil-in-water microemulsions for the oral delivery of amphotericin B. Int. J. Pharm., http://dx.doi.org/10.1016/j.ijpharm.2013.05.044.
-
(2013)
Int. J. Pharm.
-
-
Silva, A.E.1
Barratt, G.2
Chéron, M.3
Egito, E.S.T.4
-
186
-
-
80053087179
-
Oral formulation strategies to improve solubility of poorly water-soluble drugs
-
Singh, A., Worku, Z.A., Van den Mooter, G., 2011. Oral formulation strategies to improve solubility of poorly water-soluble drugs. Expert Opin. Drug Deliv. 8, 1361-1378.
-
(2011)
Expert Opin. Drug Deliv.
, vol.8
, pp. 1361-1378
-
-
Singh, A.1
Worku, Z.A.2
Van Den Mooter, G.3
-
187
-
-
33745218506
-
Visceral leishmaniasis (kala-azar): Challenges ahead
-
Singh, R.K., Pandey, H.P., Sundar, S., 2006. Visceral leishmaniasis (kala-azar): challenges ahead. Indian J. Med. Res. 123, 331-344. (Pubitemid 43905573)
-
(2006)
Indian Journal of Medical Research
, vol.123
, Issue.3
, pp. 331-344
-
-
Singh, R.K.1
Pandey, H.P.2
Sundar, S.3
-
188
-
-
12444261681
-
Challenges and new discoveries in the treatment of leishmaniasis
-
DOI 10.1007/s10156-004-0348-9
-
Singh, S., Sivakumar, R., 2004. Challenges and new discoveries in the treatment of leishmaniasis. J. Infect. Chemother. 10, 307-315. (Pubitemid 40142819)
-
(2004)
Journal of Infection and Chemotherapy
, vol.10
, Issue.6
, pp. 307-315
-
-
Singh, S.1
Sivakumar, R.2
-
189
-
-
0034527556
-
Targeting of liposomal andrographolide to L. donovani-infected macrophages in vivo
-
DOI 10.1080/107175400455137
-
Sinha, J., Mukhopadhyay, S., Das, N., Basu, M.K., 2000. Targeting of liposomal andrographolide to L. donovani-infected macrophages in vivo. Drug Deliv. 7, 209-213. (Pubitemid 32057552)
-
(2000)
Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents
, vol.7
, Issue.4
, pp. 209-213
-
-
Sinha, J.1
Mukhopadhyay, S.2
Das, N.3
Basu, M.K.4
-
190
-
-
0036182501
-
Bacopasaponin C: Critical evaluation of anti-leishmanial properties in various delivery modes
-
DOI 10.1080/107175402753413181
-
Sinha, J., Raay, B., Das, N., Medda, S., Garai, S., Mahato, S., Basu, M., 2002. Bacosaponin C: critical evaluation of anti-leishmanial properties in various delivery modes. Drug Deliv. 9, 55-62. (Pubitemid 34171335)
-
(2002)
Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents
, vol.9
, Issue.1
, pp. 55-62
-
-
Sinha, J.1
Raay, B.2
Das, N.3
Medda, S.4
Garai, S.5
Mahato, S.B.6
Basu, M.K.7
-
191
-
-
79961110340
-
Tropically stable novel oral lipid formulation of amphotericin B (iCo-010): Biodistribution and toxicity in a mouse model
-
Sivak, O., Gershkovich, P., Lin, M., Wasan, E.K., Zhao, J., Owen, D., Clement, J.G., Wasan, K.M., 2011. Tropically stable novel oral lipid formulation of amphotericin B (iCo-010): biodistribution and toxicity in a mouse model. Lipids Health Dis. 10, 135-139.
-
(2011)
Lipids Health Dis.
, vol.10
, pp. 135-139
-
-
Sivak, O.1
Gershkovich, P.2
Lin, M.3
Wasan, E.K.4
Zhao, J.5
Owen, D.6
Clement, J.G.7
Wasan, K.M.8
-
192
-
-
0343238502
-
Lipid emulsion reduces subacute toxicity of amphotericin B: A histopathological study
-
Souza, L.C., Saldiva, P.H.r.N., Campa, A., 2000. Lipid emulsion reduces subacute toxicity of amphotericin B: a histopathological study. Exp. Toxicol. Pathol. 52, 169-175. (Pubitemid 30313585)
-
(2000)
Experimental and Toxicologic Pathology
, vol.52
, Issue.2
, pp. 169-175
-
-
Souza, L.C.1
Saldiva, P.H.N.2
Campa, A.3
-
193
-
-
84861182434
-
Rational formulation development and in vitro assessment of SMEDDS for oral delivery of poorly water soluble drugs
-
Sprunk, A., Strachan, C.J., Graf, A., 2012. Rational formulation development and in vitro assessment of SMEDDS for oral delivery of poorly water soluble drugs. Eur. J. Pharm. Sci. 46, 508-515.
-
(2012)
Eur. J. Pharm. Sci.
, vol.46
, pp. 508-515
-
-
Sprunk, A.1
Strachan, C.J.2
Graf, A.3
-
194
-
-
0028283641
-
Overview of amphotericin B colloidal dispersion (Amphocil)
-
Stevens, D.A., 1994. Overview of amphotericin B colloidal dispersion (Amphocil). J. Infect. 28 (Suppl. 1), 45-49.
-
(1994)
J. Infect.
, vol.28
, Issue.SUPPL. 1
, pp. 45-49
-
-
Stevens, D.A.1
-
195
-
-
0034780949
-
Drug resistance in Indian visceral leishmaniasis
-
DOI 10.1046/j.1365-3156.2001.00778.x
-
Sundar, S., 2001. Drug resistance in Indian visceral leishmaniasis. Trop. Med. Int. Health 6, 849-854. (Pubitemid 33010870)
-
(2001)
Tropical Medicine and International Health
, vol.6
, Issue.11
, pp. 849-854
-
-
Sundar, S.1
-
196
-
-
33745224305
-
Visceral leishmaniasis - Current therapeutic modalities
-
Sundar, S., Chatterjee, M., 2006. Visceral leishmaniasis - current therapeutic modalities. Indian J. Med. Res. 123, 345-352. (Pubitemid 43905574)
-
(2006)
Indian Journal of Medical Research
, vol.123
, Issue.3
, pp. 345-352
-
-
Sundar, S.1
Chatterjee, M.2
-
197
-
-
0034110123
-
Short-course, cost-effective treatment with amphotericin B-fat emulsion cures visceral leishmaniasis
-
Sundar, S., Gupta, L.B., Rastogi, V., Agrawal, G., Murray, H.W., 2000a. Short-course, cost-effective treatment with amphotericin B-fat emulsion cures visceral leishmaniasis. Trans. R. Soc. Trop. Med. Hyg. 94, 200-204. (Pubitemid 30307297)
-
(2000)
Transactions of the Royal Society of Tropical Medicine and Hygiene
, vol.94
, Issue.2
, pp. 200-204
-
-
Sundar, S.1
Gupta, L.B.2
Rastogi, V.3
Agrawal, G.4
Murray, H.W.5
-
198
-
-
0037191710
-
Oral miltefosine for Indian visceral leishmaniasis
-
DOI 10.1056/NEJMoa021556
-
Sundar, S., Jha, T.K., Thakur, C.P., Engel, J., Sindermann, H., Fischer, C., Junge, K., Bryceson, A., Berman, J., 2002. Oral miltefosine for Indian visceral leishmaniasis. N. Engl. J. Med. 347, 1739-1746. (Pubitemid 35375612)
-
(2002)
New England Journal of Medicine
, vol.347
, Issue.22
, pp. 1739-1746
-
-
Sundar, S.1
Jha, T.K.2
Thakur, C.P.3
Engel, J.4
Sindermann, H.5
Fischer, C.6
Junge, K.7
Bryceson, A.8
Berman, J.9
-
199
-
-
34250717991
-
Injectable paromomycin for visceral leishmaniasis in India
-
DOI 10.1056/NEJMoa066536
-
Sundar, S., Jha, T.K., Thakur, C.P., Sinha, P.K., Bhattacharya, S.K., 2007. Injectable paromomycin for visceral leishmaniasis in India. N. Engl. J. Med. 356, 2571-2581. (Pubitemid 46961002)
-
(2007)
New England Journal of Medicine
, vol.356
, Issue.25
, pp. 2571-2581
-
-
Sundar, S.1
Jha, T.K.2
Thakur, C.P.3
Sinha, P.K.4
Bhattacharya, S.K.5
-
200
-
-
0034450717
-
Short-course of oral miltefosine for treatment of visceral leishmaniasis
-
DOI 10.1086/318122
-
Sundar, S., Makharia, A., More, D.K., Agrawal, G., Voss, A., Fischer, C., Bachmann, P., Murray, H.W., 2000b. Short-course of oral miltefosine for treatment of visceral leishmaniasis. Clin. Infect. Dis. 31, 1110-1113. (Pubitemid 32299377)
-
(2000)
Clinical Infectious Diseases
, vol.31
, Issue.4
, pp. 1110-1113
-
-
Sundar, S.1
Makharia, A.2
More, D.K.3
Agrawal, G.4
Voss, A.5
Fischer, C.6
Bachmann, P.7
Murray, H.W.8
-
201
-
-
1042288575
-
Amphotericin B Treatment for Indian Visceral Leishmaniasis: Conventional versus Lipid Formulations
-
DOI 10.1086/380971
-
Sundar, S., Mehta, H., Suresh, A.V., Singh, S.P., Rai, M., Murray, H.W., 2004. Amphotericin B treatment for Indian visceral leishmaniasis: conventional versus lipid formulations. Clin. Infect. Dis. 38, 377-383. (Pubitemid 38200114)
-
(2004)
Clinical Infectious Diseases
, vol.38
, Issue.3
, pp. 377-383
-
-
Sundar, S.1
Mehta, H.2
Suresh, A.V.3
Singh, S.P.4
Rai, M.5
Murray, H.W.6
-
202
-
-
18944370727
-
Availability of miltefosine for the treatment of kala-azar in India
-
Sundar, S., Murray, H.W., 2005. Availability of miltefosine for the treatment of kalaazar in India. Bull. World Health Organ. 83, 394-395. (Pubitemid 40704871)
-
(2005)
Bulletin of the World Health Organization
, vol.83
, Issue.5
, pp. 394-395
-
-
Sundar, S.1
Murray, H.W.2
-
203
-
-
36448953526
-
Miltefosine in the treatment of leishmaniasis: Clinical evidence for informed clinical risk management
-
Sundar, S., Olliaro, P.L., 2007. Miltefosine in the treatment of leishmaniasis: clinical evidence for informed clinical risk management. Ther. Clin. Risk Manage. 3, 733-740. (Pubitemid 350162073)
-
(2007)
Therapeutics and Clinical Risk Management
, vol.3
, Issue.5
, pp. 733-740
-
-
Sundar, S.1
Olliaro, P.L.2
-
204
-
-
29444452265
-
Treatment of visceral leishmaniasis
-
DOI 10.1517/14656566.6.16.2821
-
Sundar, S., Rai, M., 2005. Treatment of visceral leishmaniasis. Expert Opin. Pharmacother. 6, 2821-2829. (Pubitemid 43009545)
-
(2005)
Expert Opinion on Pharmacotherapy
, vol.6
, Issue.16
, pp. 2821-2829
-
-
Sundar, S.1
Rai, M.2
-
205
-
-
79958748637
-
Pharmacokinetics of oral sitamaquine taken with or without food and safety and efficacy for treatment of visceral leishmaniais: A randomized study in Bihar, India
-
Sundar, S., Sinha, P.K., Dixon, S.A., Buckley, R., Miller, A.K., Mohamed, K., Al-Banna, M., 2011. Pharmacokinetics of oral sitamaquine taken with or without food and safety and efficacy for treatment of visceral leishmaniais: a randomized study in Bihar, India. Am. J. Trop. Med. Hyg. 84, 892-900.
-
(2011)
Am. J. Trop. Med. Hyg.
, vol.84
, pp. 892-900
-
-
Sundar, S.1
Sinha, P.K.2
Dixon, S.A.3
Buckley, R.4
Miller, A.K.5
Mohamed, K.6
Al-Banna, M.7
-
206
-
-
1842711882
-
Formation and stability of nanoemulsions
-
Tadros, T., Izquierdo, P., Esquena, J., Solans, C., 2004. Formation and stability of nanoemulsions. Adv. Colloid Interf. Sci. 108-109, 303-318.
-
(2004)
Adv. Colloid Interf. Sci.
, vol.108-109
, pp. 303-318
-
-
Tadros, T.1
Izquierdo, P.2
Esquena, J.3
Solans, C.4
-
207
-
-
7444224004
-
Oil-in-water lipid emulsions: Implications for parenteral and ocular delivering systems
-
DOI 10.1016/j.plipres.2004.09.001, PII S016378270400027X
-
Tamilvanan, S., 2004. Oil-in-water lipid emulsions: implications for parenteral and ocular delivering systems. Progr. Lipid Res. 43, 489-533. (Pubitemid 39441344)
-
(2004)
Progress in Lipid Research
, vol.43
, Issue.6
, pp. 489-533
-
-
Tamilvanan, S.1
-
208
-
-
0032726663
-
Release characteristics of endogenous constituents by exposure of small intestine to modified beta-cyclodextrins
-
Tanino, T., Ogiso, T., Iwaki, M., Yamaguchi, T., Kakehi, K., 1999. Release characteristics of endogenous constituents by exposure of small intestine to modified betacyclodextrins. Biol. Pharm. Bull. 22, 1099-1105. (Pubitemid 29507951)
-
(1999)
Biological and Pharmaceutical Bulletin
, vol.22
, Issue.10
, pp. 1099-1105
-
-
Tanino, T.1
Ogiso, T.2
Iwaki, M.3
Yamaguchi, T.4
Kakehi, K.5
-
209
-
-
0035295431
-
Leishmania species, drug unresponsiveness and visceral leishmaniasis in Bihar, India
-
DOI 10.1016/S0035-9203(01)90160-9
-
Thakur, C.P., Dedet, J.P., Narain, S., Pratlong, F., 2001. Leishmania species, drug unresponsiveness and visceral leishmaniasis in Bihar, India. Trans. R. Soc. Trop. Med. Hyg. 95, 187-189. (Pubitemid 34947385)
-
(2001)
Transactions of the Royal Society of Tropical Medicine and Hygiene
, vol.95
, Issue.2
, pp. 187-189
-
-
Thakur, C.P.1
Dedet, J.P.2
Narain, S.3
Pratlong, F.4
-
210
-
-
6444223571
-
Epidemiological, clinical & pharmacological study of antimony-resistant visceral leishmaniasis in Bihar, India
-
Thakur, C.P., Narayan, S., Ranjan, A., 2004. Epidemiological, clinical & pharmacological study of antimony-resistant visceral leishmaniasis in Bihar, India. Indian J. Med. Res. 120, 166-172. (Pubitemid 39406044)
-
(2004)
Indian Journal of Medical Research
, vol.120
, Issue.3
, pp. 166-172
-
-
Thakur, C.P.1
Narayan, S.2
Ranjan, A.3
-
211
-
-
0035478758
-
Chitosan and its derivatives as intestinal absorption enhancers
-
DOI 10.1016/S0169-409X(01)00180-6, PII S0169409X01001806
-
Thanou, M., Verhoef, J.C., Junginger, H.E., 2001. Chitosan and its derivatives as intestinal absorption enhancers. Adv. Drug Deliv. Rev. 50 (Suppl. 1), S91-S101. (Pubitemid 32905357)
-
(2001)
Advanced Drug Delivery Reviews
, vol.50
, Issue.SUPPL. 1
-
-
Thanou, M.1
Verhoef, J.C.2
Junginger, H.E.3
-
212
-
-
79961029192
-
Recent advances in leishmaniasis treatment
-
Tiuman, T.S., Santos, A.O., Ueda-Nakamura, T., Filho, B.P.D., Nakamura, C.V., 2011. Recent advances in leishmaniasis treatment. Int. J. Infect. Dis. 15, e525-e532.
-
(2011)
Int. J. Infect. Dis.
, vol.15
-
-
Tiuman, T.S.1
Santos, A.O.2
Ueda-Nakamura, T.3
Filho, B.P.D.4
Nakamura, C.V.5
-
213
-
-
33845566719
-
Formulation and characterization of amphotericin B-chitosan-dextran sulfate nanoparticles
-
DOI 10.1016/j.ijpharm.2006.08.013, PII S0378517306006600
-
Tiyaboonchai, W., Limpeanchob, N., 2007. Formulation and characterization of amphotericin B-chitosan-dextran sulfate nanoparticles. Int. J. Pharm. 329, 142-149. (Pubitemid 44937518)
-
(2007)
International Journal of Pharmaceutics
, vol.329
, Issue.1-2
, pp. 142-149
-
-
Tiyaboonchai, W.1
Limpeanchob, N.2
-
214
-
-
18744405403
-
Targeted delivery of arjunglucoside I using surface hydrophilic and hydrophobic nanocarriers to combat experimental leishmaniasis
-
Tyagi, R., Lala, S., Verma, A.K., Nandy, A.K., Mahato, S.B., Maitra, A., Basu, M.K., 2005. Targeted delivery of arjunglucoside I using surface hydrophilic and hydrophobic nanocarriers to combat experimental leishmaniasis. J. Drug Target. 13, 161-171.
-
(2005)
J. Drug Target.
, vol.13
, pp. 161-171
-
-
Tyagi, R.1
Lala, S.2
Verma, A.K.3
Nandy, A.K.4
Mahato, S.B.5
Maitra, A.6
Basu, M.K.7
-
215
-
-
58149464297
-
Antileishmanial activity, pharmacokinetics and tissue distribution studies of mannose-grafted amphotericin B lipid nanospheres
-
Veerareddy, P.R., Vobalaboina, V., Ali, N., 2009. Antileishmanial activity, pharmacokinetics and tissue distribution studies of mannose-grafted amphotericin B lipid nanospheres. J. Drug Target. 17, 140-147.
-
(2009)
J. Drug Target.
, vol.17
, pp. 140-147
-
-
Veerareddy, P.R.1
Vobalaboina, V.2
Ali, N.3
-
216
-
-
0016166315
-
The influence of pH, Ca2+ and protein on the thermotropic behaviour of the negatively charged phospholipid, phosphatidylglycerol
-
Verkleij, A.J., de Kruyff, B., Ververgaert, P.H., Tocanne, J.F., van Deenen, L.L., 1974. The influence of pH, Ca2+ and protein on the thermotropic behaviour of the negatively charged phospholipid, phosphatidylglycerol. Biochim. Biophys. Acta 339, 432-437.
-
(1974)
Biochim. Biophys. Acta
, vol.339
, pp. 432-437
-
-
Verkleij, A.J.1
De Kruyff, B.2
Ververgaert, P.H.3
Tocanne, J.F.4
Van Deenen, L.L.5
-
217
-
-
79957676878
-
Loading and release of amphotericin-B from biodegradable poly(lactic-co-glycolic acid) nanoparticles
-
Verma, R.K., Pandya, S., Misra, A., 2011. Loading and release of amphotericin-B from biodegradable poly(lactic-co-glycolic acid) nanoparticles. J. Biomed. Nanotechnol. 7, 118-120.
-
(2011)
J. Biomed. Nanotechnol.
, vol.7
, pp. 118-120
-
-
Verma, R.K.1
Pandya, S.2
Misra, A.3
-
218
-
-
84859612403
-
Discovery of factors linked to antimony resistance in Leishmania panamensis through differential proteome analysis
-
Walker, J., Gongora, R., Vasquez, J.-J., Drummelsmith, J., Burchmore, R., Roy, G., Ouellette, M., Gomez, M.A., Saravia, N.G., 2012. Discovery of factors linked to antimony resistance in Leishmania panamensis through differential proteome analysis. Mol. Biochem. Parasitol. 183, 166-176.
-
(2012)
Mol. Biochem. Parasitol.
, vol.183
, pp. 166-176
-
-
Walker, J.1
Gongora, R.2
Vasquez, J.-J.3
Drummelsmith, J.4
Burchmore, R.5
Roy, G.6
Ouellette, M.7
Gomez, M.A.8
Saravia, N.G.9
-
219
-
-
64149117052
-
Development and characterization of oral lipid-based amphotericin B formulations with enhanced drug solubility, stability and antifungal activity in rats infected with Aspergillus fumigatus or Candida albicans
-
Wasan, E.K., Bartlett, K., Gershkovich, P., Sivak, O., Banno, B., Wong, Z., Gagnon, J., Gates, B., Leon, C.G., Wasan, K.M., 2009. Development and characterization of oral lipid-based amphotericin B formulations with enhanced drug solubility, stability and antifungal activity in rats infected with Aspergillus fumigatus or Candida albicans. Int. J. Pharm. 372, 76-84.
-
(2009)
Int. J. Pharm.
, vol.372
, pp. 76-84
-
-
Wasan, E.K.1
Bartlett, K.2
Gershkovich, P.3
Sivak, O.4
Banno, B.5
Wong, Z.6
Gagnon, J.7
Gates, B.8
Leon, C.G.9
Wasan, K.M.10
-
220
-
-
78650690322
-
A novel tropically stable oral amphotericin B formulation (iCo-010) exhibits efficacy against visceral leishmaniasis in a murine model
-
Wasan, E.K., Gershkovich, P., Zhao, J., Zhu, X., Werbovetz, K., Tidwell, R.R., Clement, J.G., Thornton, S.J., Wasan, K.M., 2010. A novel tropically stable oral amphotericin B formulation (iCo-010) exhibits efficacy against visceral leishmaniasis in a murine model. PLoS Negl. Trop. Dis. 4, e913.
-
(2010)
PLoS Negl. Trop. Dis.
, vol.4
-
-
Wasan, E.K.1
Gershkovich, P.2
Zhao, J.3
Zhu, X.4
Werbovetz, K.5
Tidwell, R.R.6
Clement, J.G.7
Thornton, S.J.8
Wasan, K.M.9
-
221
-
-
0036411713
-
The role of lymphatic transport in enhancing oral protein and peptide drug delivery
-
DOI 10.1081/DDC-120014573
-
Wasan, K.M., 2002. The role of lymphatic transport in enhancing oral protein and peptide drug delivery. Drug Dev. Ind. Pharm. 28, 1047-1058. (Pubitemid 35278830)
-
(2002)
Drug Development and Industrial Pharmacy
, vol.28
, Issue.9
, pp. 1047-1058
-
-
Wasan, K.M.1
-
222
-
-
84877259367
-
Strategies to address low drug solubility in discovery and development
-
Williams, H.D., Trevaskis, N.L., Charman, S.A., Shanker, R.M., Charman, W.N., Pouton, C.W., Porter, C.J., 2013. Strategies to address low drug solubility in discovery and development. Pharmacol. Rev. 65, 315-499.
-
(2013)
Pharmacol. Rev.
, vol.65
, pp. 315-499
-
-
Williams, H.D.1
Trevaskis, N.L.2
Charman, S.A.3
Shanker, R.M.4
Charman, W.N.5
Pouton, C.W.6
Porter, C.J.7
-
223
-
-
0018653707
-
2+-induced fusion of phospholipid vesicles monitored by mixing of aqueous contents
-
DOI 10.1038/281690a0
-
Wilschut, J., Papahadjopoulos, D., 1979. Calcium induced fusion of phospholipid vesicles monitored by mixing of aqueous contents. Nature 281, 690-692. (Pubitemid 10249051)
-
(1979)
Nature
, vol.281
, Issue.5733
, pp. 690-692
-
-
Wilschut, J.1
Papahadjopoulos, D.2
-
224
-
-
78650180318
-
Development of biodegradable porous starch foam for improving oral delivery of poorly water soluble drugs
-
Wu, C., Wang, Z., Zhi, Z., Jiang, T., Zhang, J., Wang, S., 2011. Development of biodegradable porous starch foam for improving oral delivery of poorly water soluble drugs. Int. J. Pharm. 403, 162-169.
-
(2011)
Int. J. Pharm.
, vol.403
, pp. 162-169
-
-
Wu, C.1
Wang, Z.2
Zhi, Z.3
Jiang, T.4
Zhang, J.5
Wang, S.6
-
225
-
-
80052168589
-
Intestinal lymphatic transport for drug delivery
-
Yanez, J.A., Wang, S.W., Knemeyer, I.W., Wirth, M.A., Alton, K.B., 2011. Intestinal lymphatic transport for drug delivery. Adv. Drug Deliv. Rev. 63, 923-942.
-
(2011)
Adv. Drug Deliv. Rev.
, vol.63
, pp. 923-942
-
-
Yanez, J.A.1
Wang, S.W.2
Knemeyer, I.W.3
Wirth, M.A.4
Alton, K.B.5
-
226
-
-
77955317693
-
Dual responsive copolymer micelles for drug controlled release
-
Yang, L., Guo, C., Jia, L., Liang, X., Liu, C., Liu, H., 2010. Dual responsive copolymer micelles for drug controlled release. J. Colloid Interf. Sci. 350, 22-29.
-
(2010)
J. Colloid Interf. Sci.
, vol.350
, pp. 22-29
-
-
Yang, L.1
Guo, C.2
Jia, L.3
Liang, X.4
Liu, C.5
Liu, H.6
-
227
-
-
80053504272
-
Optimization of the preparation process for an oral phytantriol-based amphotericin B cubosomes
-
Article ID 308016
-
Yang, Z., Peng, X., Tan, Y., Chen, M., Zhu, X., Feng, M., Xu, Y., Wu, C., 2011. Optimization of the preparation process for an oral phytantriol-based amphotericin B cubosomes. J. Nanomater. 2011, Article ID 308016, 10 pages.
-
(2011)
J. Nanomater.
, vol.2011
, pp. 10
-
-
Yang, Z.1
Peng, X.2
Tan, Y.3
Chen, M.4
Zhu, X.5
Feng, M.6
Xu, Y.7
Wu, C.8
-
228
-
-
24644501726
-
The sensitivity of clinical isolates of Leishmania from Peru and Nepal to miltefosine
-
Yardley, V., Croft, S.L., De Doncker, S., Dujardin, J.C., Koirala, S., Rijal, S., Miranda, C., Llanos-Cuentas, A., Chappuis, F., 2005. The sensitivity of clinical isolates of leishmania from Peru and Nepal to miltefosine. Am. J. Trop. Med. Hyg. 73, 272-275. (Pubitemid 41278697)
-
(2005)
American Journal of Tropical Medicine and Hygiene
, vol.73
, Issue.2
, pp. 272-275
-
-
Yardley, V.1
Croft, S.L.2
De Doncker, S.3
Dujardin, J.-C.4
Koirala, S.5
Rijal, S.6
Miranda, C.7
Llanos-Cuentas, A.8
Chappuis, F.9
-
229
-
-
13844267381
-
Drug delivery by lipid cochleates
-
DOI 10.1016/S0076-6879(05)91018-5
-
Zarif, L., 2005. Drug delivery by lipid cochleates. Methods Enzymol. 391, 314-329. (Pubitemid 40254043)
-
(2005)
Methods in Enzymology
, vol.391
, Issue.SPEC. ISS.
, pp. 314-329
-
-
Zarif, L.1
-
230
-
-
0034521317
-
Cochleates: New lipid-based drug delivery system
-
Zarif, L., Graybill, J.R., Perlin, D., Mannino, R.J., 2000a. Cochleates: new lipid-based drug delivery system. J. Liposome Res. 10, 523-538. (Pubitemid 32047474)
-
(2000)
Journal of Liposome Research
, vol.10
, Issue.4
, pp. 523-538
-
-
Zarif, L.1
Graybill, J.R.2
Perlin, D.3
Mannino, R.J.4
-
231
-
-
0034037471
-
Antifungal activity of amphotericin B cochleates against Candida albicans infection in a mouse model
-
DOI 10.1128/AAC.44.6.1463-1469.2000
-
Zarif, L., Graybill, J.R., Perlin, D., Najvar, L., Bocanegra, R., Mannino, R.J., 2000b. Antifungal activity of amphotericin B cochleates against Candida albicans infection in a mouse model. Antimicrob. Agents Chemother. 44, 1463-1469. (Pubitemid 30340780)
-
(2000)
Antimicrobial Agents and Chemotherapy
, vol.44
, Issue.6
, pp. 1463-1469
-
-
Zarif, L.1
Graybill, J.R.2
Perlin, D.3
Najvar, L.4
Bocanegra, R.5
Mannino, R.J.6
-
232
-
-
84874424798
-
-
BioDelivery Sciences International, Inc., University of Medicine and Dentistry of New Jersey, USA
-
Zarif, L., Jin, T., Segarra, I., Mannino, R.J., 2003. Hydrogel-isolated Cochleate Formulations, Process of Preparation and Their Use for the Delivery of Biologically Relevant Molecules. BioDelivery Sciences International, Inc., University of Medicine and Dentistry of New Jersey, USA.
-
(2003)
Hydrogel-isolated Cochleate Formulations, Process of Preparation and Their Use for the Delivery of Biologically Relevant Molecules
-
-
Zarif, L.1
Jin, T.2
Segarra, I.3
Mannino, R.J.4
-
233
-
-
84874304861
-
Porous starch based self-assembled nano-delivery system improvesthe oral absorption of lipophilic drug
-
Zhang, Z., Huang, J., Jiang, S., Liu, Z., Gu, W., Yu, H., Li, Y., 2013. Porous starch based self-assembled nano-delivery system improvesthe oral absorption of lipophilic drug. Int. J. Pharm. 444, 162-168.
-
(2013)
Int. J. Pharm.
, vol.444
, pp. 162-168
-
-
Zhang, Z.1
Huang, J.2
Jiang, S.3
Liu, Z.4
Gu, W.5
Yu, H.6
Li, Y.7
|